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Nail tissue has been proposed as a biomarker for body burden of occupational exposure 
to manganese from welding fumes.  Though recent studies have shown correlation 
between manganese exposure and both nail tissue concentration as well as concentrations 
in dopaminergic regions of the brain, concerns of the validity of nail tissue as a biomarker 
have arisen due to the potential for exogenous contamination of Mn to undermine the 
quantization of endogenous Mn in nail.  Previous studies have used a cleaning method of 
1% Triton X-100 surfactant plus sonication in order to attempt to remove exogenous 
welding fume contamination.  Determination of the potential level of exogenous Mn from 
welding fume on welder nail tissue was investigated. In addition, an intentional welding 
fume contamination methodology was developed in order to deposit welding fume Mn 
onto control nail samples in a within-subject design in order to test the efficacy of the 
prior nail tissue cleaning method.  Paired sample fingernails from welders exposed to gas 
metal arc welding (GMAW) welding fume were digested and analyzed by inductively 
coupled plasma-mass spectrometry (ICP-MS).  Uncleaned welder fingernails had a mean 
of 8.78 µg/g Mn (LCL = 5.58, UCL = 11.99) while those cleaned via the prior cleaning 
xiii 
 
method showed a mean of 3.22 µg/g Mn (LCL = 3.07, UCL = 3.37).  Results of a 
Cochran method two-sample t-test between cleaned and uncleaned welder fingernails 
showed significance at p=0.0117 and a Wilcoxon t-distribution 2-sided test approached 
significance at p=0.0671, indicating that exogenous Mn contamination is likely a threat to 
validity of nail tissue as a biomarker of body burden.  GMAW welding fume exposed 
uncleaned control subject nails (at twice the level of exogenous Mn seen in the welder 
fingernails) had a mean concentration of 11.35 µg/g Mn (LCL95 = 9.41, UCL95 = 13.30) 
while unexposed uncleaned control nails had a mean concentration of 0.42 µg/g Mn 
(LCL95 = 0.23, UCL95 = 0.60).  Results of a Cochran method two-sample t-test between 
exposed and unexposed uncleaned control fingernails showed significance at p=0.0001 
and a Wilcoxon t-distribution 2-sided test approached significance at p=0.0172, 
indicating that the method of GMAW welding fume contamination effectively 
contaminated the tissue with welding fume Mn.  Exposed cleaned control fingernails had 
a mean of 0.63 µg/g Mn (LCL95 = 0.48, UCL95 = 0.79), while those unexposed prior to 
cleaning showed a mean of 0.14 µg/g Mn (LCL95 = 0.12, UCL95 = 0.17).  Results of a 
Cochran method two-sample t-test between exposed and unexposed cleaned control nails 
showed significance at p=0.0002 and a Wilcoxon t-distribution 2-sided test approached 
significance at p=0.00027, indicating that while not all exogenous Mn contamination was 
eliminated by the cleaning method, , the residual contamination amounted to only 4.45% 
± 1.23% (95.55% of the contamination was removed).   The results indicate that nail 
tissue can be cleaned effectively of the majority of exogenous Mn exposure, pointing to 
the utility of nail tissue as a biomarker for welding fume Mn internal exposure and likely 
occupational and environmental exposures to additional metals as well. 
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CHAPTER 1. INTRODUCTION 
1.1 Introduction 
Occupational exposure to welding fume is a well-documented workplace hazard in 
facilities implementing the use of welding techniques for metal fabrication.  Though 
worker exposure assessments can lead to insight of the potential exposure a worker may 
experience, they are at best an indirect measure of exposure with somewhat limited 
reliability. Exposure assessments for welding fume often involve work history and 
dietary questionnaires, personal breathing zone (PBZ) and work area air monitoring, 
work logs and data, type of welding and welding materials, use and type of respirators 
and other PPE as well as local and general exhaust ventilation.  The goal is to determine 
the exposure to the various hazardous constituents contained in welding fume, chiefly 
manganese, iron, lead, and copper in typical mild steel alloy welding wire and chrome 
and zinc respectively when the welding work involve stainless steel or galvanized metal. 
 
Obviously it would be very beneficial for industrial hygiene and occupational health 
workers to be able to quantize workers exposure to these welding fume components via 
more direct methods.  Having a direct measurement of the distinct metals, associated with 
neurologic effects, from welding fume exposure would offer key insight to the overall 
exposure of workers to welding fumes.  The uptake of metals in welding fumes are 
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typically from aerosol states of the various metals which are quickly oxidized after 
condensation in the air.  Unlike many organic contaminants, metals are persistent in the 
body as they cannot be broken down into smaller organic molecules, but can only 
undergo changes in oxidation state and potentially bind or chelate to large biomolecules.  
Although metabolic excretion pathways such as urine, feces, sweat, and exhaled air do 
account for large percentages of metal exposure to be excreted from the body, 
metabolism does not actually eliminate metal intake entirely.  For most metals a 
significant fraction will persist in one state or another which if still present in bodily fluid 
or tissue, can be used as a biomarker of the metal exposure.1 
 
Adroit use of legitimately accurate biomarkers for assessment of worker welding fume 
exposure helps researchers strengthen the internal validity of their study by having a 
second measure of exposure in addition to the typical exposure assessment methods such 
as air sampling and work history data collection.  This will help ensure there is less 
likelihood of measurement bias as the exposure assessment and biological tissue 
assessment should be related and any indication of inconsistencies could alert an astute 
researcher of potential problems in protocol, methodology, equipment or reagents. 
According to Eastman2, it is important to identify adequate biomarkers of exposure for 
metal exposures because they most likely reveal the “integration of the internalized dose 
over time”. In essence, the true goal of exposure assessment is to demonstrate an 
exposure-effect relationship and researchers should strive to identify the measure that 
most effectively and accurately demonstrates this effect.  The belief is that external 
assessments of exposure (e.g. personal breathing zone air monitoring, etc.) will always 
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leave some doubt as to whether they are true representations of the internalized dose, 
whereas biomarkers which can be shown to directly reflect the physically incorporated 
toxicant (body burden).  For example, there should be better prediction of actual risk by 
an effective chronologically integrated biomarker such as Mn in keratin rather than 
exogenic references such as air concentrations or indirect measures such as work histories 
or hour welding.2 
 
Even if, however, the a biomarker is shown to be a valid, objective, precise, and reliable 
measurement of exposure with less bias than other alternatives, there are certain 
limitations involved as with biomarkers as well.  Laboratory errors are possible, though 
this is no different to lab errors possible in the analysis of air sampling filters and quite 
akin to transcription and analysis errors in the use of questionnaire and historical data.  
Timing can be a factor as well.  As will be discussed in more detail, different types of 
metals have varying half-lives in various biological tissues.  The desired time-window of 
exposure which is to be measured must parallel the biomarkers chronological expression 
of the metal exposure in a fashion which will allow meaningful observations.  Time can 
be another factor as well.  The proper allowable storage time of samples in various states 
throughout the process of collection, preparation, and final analysis, must be determined.  
The samples must not be allowed to degenerate, lose concentration, or suffer integrity 
loss such that they are no longer valid.   Expense may also play a negative role as 
analysis of some biomarkers may be more costly than other exposure assessment methods. 
Finally there is also the question of acceptability.  There may be ethical questions related 
to the use of particular biomarkers, such as cerebral-spinal fluid used with children. The 
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subjects of the biomarker analysis must be made aware of the overall risks and benefits 
and must deem the intrusion of the biomarker sampling to be acceptable.26 
 
1.2 Body Fluids As Biomarkers of Metal Exposure 
Techniques for analysis of body fluids such as blood and urine as biomarkers of metal 
exposure have been available to researchers for a long time.  Higher blood serum and 
urine concentrations of typical welding fume related metals such as Mn have been found 
in welders exposed to welding fume compared to control subjects, however these fluids 
may only be useful for testing relatively recent (acute) exposures.3  Excessive blood 
serum and urine concentrations of many metals such as Mn, quickly diminish to 
homeostatic levels due to hepatic and renal metabolism pathways.  Unfortunately this 
leads to limited utility of these fluids as a biomarker of metal exposures, their value being 
primarily that of comparing acute exposures in short time frame models to validate very 
recent personal and area exposure air monitoring.   
 
Santamaria reviewed a great deal of research regarding various attempts to correlate 
blood and urine, as biological measures of Mn exposure, with measures of neurological 
dysfunction (e.g. measures of memory, word recall, hand-eye coordination, etc.) and 
found little consensus on the use of these fluids as biomarkers of exposure related to 
adverse health effects of Mn.4  Lees-Haley performed a meta-analysis of 20 separate 
research studies performed between 1997 and 2002 which looked at occupational 
exposure to Mn.  The analysis concluded that urine and blood did not show correlation 
with air monitoring assessments or total years of exposure to the worker.5 
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Laohaudomchok also showed that Mn exposure over work shift was not correlated to 
blood of urine.  His study used both apprentice and professional welders attending 
boilermaker welding school.  Laohaudomchok used analysis of Mn exposure over work 
shifts and cumulative exposure assessments in an attempt to determine if Mn 
concentrations in certain human biological tissues were correlated to these measures and 
thus could be considered effective biomarkers of Mn exposure. The study determined that 
both blood and urine were not effective measures of Mn exposure.6 
 
1.3 Keratin Tissue As Biomarker of Metal Exposure 
In light of limited utility of blood and urine as biomarkers due to the short retention 
period of the metals in those fluids, keratin based tissue such as nail and hair material has 
been proposed as an alternative.  Many studies have looked at the potential for nail and 
hair, keratin based tissues, to be used as biomarkers of various metal exposures.  
Longnecker demonstrated that selenium in toenails represented an integrated exposure 
over the typical growth window of toenail (7-12 month timeframe).7  Garland showed 
that long-term reproducibility of selenium mercury and arsenic concentrations in toenail 
correlated to dietary intake.8   Palmeri discussed the advantages which keratin based 
tissues have over body fluids as biomarkers.  Palmeri’s primary concern was the 
incorporation of drug metabolites into the keratin matrix, but the same mechanisms come 
into play in the deposition of trace metals into the nail or hair tissue as well. Palmeri 
states that there are three basic reasons why keratin tissue may prove much more useful 
as a biomarker of metal exposure in long-term exposure scenarios.  As a biological 
material, keratin has a strong chemical and physical integrity, a natural affinity for metals 
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as it grows, and a relatively slow growth rate which can assist more long-term modeling 
of exposure.9 
 
Robust nail and hair keratin proteins are able to bear substantial physical and chemical 
attack without incurring significant damage.  Nail and hair keratin contains high levels of 
cysteine, an amino acid containing sulfhydryl-bonded thiol side chains which leads to 
strong covalent disulfide bonds through coupling of thiol groups from adjacent molecules. 
This is one reason keratin based hair and nail tissue is so strong and resilient.9 
 
Closely linked to the nature of keratin stability and strength is the tissue’s distinctive 
affinity for metals of interest such as Mn.  It has been shown that the high levels of thiol 
groups (from cysteine) in nail and hair keratin are responsible for the high affinity of 
metals to the forming keratin tissue.9 
 
The lengthy time scale for growth of both nail tissue (typically 1.6 mm/month 10 
corresponding to 6-12 months 7, 11, 12  for an average full big toe growth length of 20mm 
and roughly half that for fingernails 10,13) and hair tissue (typically 250 µm/day growth 
rate2, 14) can also allow these tissue to be used to give a rough chronological distribution 
of the workers exposure if analyzed segmentally.  Such data can be plotted against the 
personal or area exposure in a timeline to validate and correlate the relationship between 
biomarker and air exposure as well as to measurements of neurologic degeneration.11  
While the variation associated in human toenail growth does, could be a potential 
confounder of nail as a biomarker for metal exposure, Grashow proposes that any growth 
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rate variation would not correlate to exposure measures, such as welding hours or air 
concentrations, and would thus not harm the internal validity of studies tying nail 
concentrations to such measures.11 
 
Once a thorough understanding of the use of nail and hair as biomarkers for metal 
exposures exists, future uses of this type of analysis could be implemented.  Beyond the 
research realm, new uses could include medical screening for metals exposures during 
typical medical surveillance before job placement (to get worker-specific baseline data), 
periodically during the term of employment (to help assess on-site exposure), and at time 
of termination or job transfer (to verify the workers exposure upon leaving the company). 
 
1.4 Use of Nail Tissue As Biomarker of Welding Fume Mn Exposure 
Sriram demonstrated that Mn accumulation in nail clippings is strongly correlated with 
brain tissue concentration of Mn.  In his study, he intratracheally dosed rats with 
dissolved suspended fume from gas metal arc welding (GMAW) and MMAW (manual 
metal arc welding) to ensure the absolute intake of Mn.   Sriram reported that Mn in the 
striatum (R2 = 0.9386; P<0.0001) and the midbrain (R2 = 0.9332; P<0.0001) were highly 
correlated to Mn concentration in toenail tissue.  He was also able to demonstrate that 
dopaminergic abnormalities such as changes in mitochondrial function and expression of 
proteins (Th, Park5, Park7), which are associated with neurodegeneration in Parkinson’s 
Disease and Parkinsonism, were linked to Mn concentrations in these same brain regions.  
Thus his study showed direct correlations between Mn exposure markers, both brain 
tissue concentration and nail tissue concentration, and neurological degeneration.  He 
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concluded that Mn in keratin tissue is a better predictor of Mn accumulation and exposure 
than blood and urine.  All of these facts help validate the use of Mn in nail tissue as a 
good biomarker of neurotoxicological effect from Mn in welding fume exposure.15  
 
Laohaudomchok, in a previously study, tested toenail for its correlation to Mn exposure 
measures.  After adjusting his data for potentially confounding variables such as age and 
diet, significant correlation was found between various ranges of cumulative exposure 
between the 7 and 12 month time windows prior to nail sampling, corresponding 
approximately to the time frame of the sample clippings actual growth at the cuticle.  
Laohaudomchok likewise concluded that while blood and urine were poor indicators of 
cumulative Mn exposure, toenail tissue did seem to be a valid biomarker of Mn 
exposure.6 
 
Grashow used the same cohort which Laohaudomchok had studied but focused on using 
a far simpler measure of external exposure, total weld hours.  Toenail clippings were 
acquired from welders and analyzed via dynamic reaction cell-inductively coupled 
plasma-mass spectrometry (DRC-ICP-MS) after cleaning and digestion.  To remove the 
suspect exogenous welding fume contamination Grashow sonicated the tissue samples in 
a surfactant solution (1% Triton X-100) for 20 minutes followed by repeated rinses with 
Milli-Q water.  Results indicated that cumulative lifetime years of welding work were not 
related to hours welded in past year which Grashow accepted as evidence that years 
working as a welder is not a confounding variable in relation to toenail as a biomarker of 
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welding fume Mn exposure from the past year. This is significant because of the 
inclusion of both professional and apprentice welders in the cohort.11 
 
Since the toenail Mn concentrations were not normally distributed, Grashow compared 
log-transformed toenail concentration, adjusted for BMI, smoking status, age, and 
respirator use, with weld hours.  Toenail Mn levels had a positive associatation only with 
weld hours from the previous 7-9 month yearly quarter (β = 0.0032, p < 0.001). Age, 
BMI and smoking status did not appear to have significant correlation to toenail Mn in 
any of the models tested. Respirator use hours, however, was negatively associated to 
toenail Mn levels in the fourth quarter (10-12 months prior to clipping; β = -0.1877, p = 
0.02).11  Overall median Mn concentration in toenail for the cohort11 was 0.81 µg/g 
similar to the 0.8 µg/g seen in the same cohort in the Laohaudomchok study6 but 
significantly lower than other studies, notably a Portuguese miner study which found a 
mean toenail concentration of 2.5 µg/g.16  The cohort used in the Grashow and 
Laohaudomchok studies were welders involved in a boilermaker welding school in which 
welders worked in large, temperature controlled workstations that were equipped with 
local exhaust ventilation (LEV).6  It is assumed that welders in less clean environments 
and without the benefit of LEV and respirator use are much more likely to exhibit 
significantly higher nail concentrations of Mn relative to a greater airborne exposure of 




1.5 Toenail Tissue As Biomarker for The Wabash Study 
For an ongoing exposure assessment of welders and controls through a research study 
(The Wabash Study) conducted at Purdue University under the guidance of Drs. Ulrike 
Dydak and Frank Rosenthal, direct measurements of cumulative exposure to Mn relative 
to known periods of exposure were compared to the welders’ current and past exposure 
status.  Toenail tissue was selected as a biomarker of Mn internal exposure due to its 
distinct affinity for metals such as Mn during its growth and the fact that toenail Mn 
concentration level is currently among the most promising biomarkers for Mn intake as 
shown in recent studies.6, 15 
 
As The Wabash Study aims to related welding fume manganese exposures to overall 
neurological deficit, external exposure assessment (such as air sampling), and brain 
deposition of manganese (determined by MRI analysis), it is imperative that any 
biomarker for manganese should consistently reflect actual exposure intake of the 
individual subject for a distinct time window.  It may be determined that the Mn 
accumulation in nail tissue is actually representative of a fraction of the true total intake 
(due to possible alternative exposure routes such as olfactory nerve route), however as 
long nail tissue Mn concentration is found to represent a constant fraction of the total 
body burden, nail tissue will likely be a useful biomarker. As mentioned above, at least 
some evidence to this effect is seen in Sriram’s work. 
 
Toenail tissue is being used preferentially over fingernail in The Wabash Study in order 
to minimize the effect of exogenous contamination of welding fume particulate matter to 
11 
 
the nail tissue as workers’ feet are typically somewhat protected in the work environment, 
in contrast to fingernails.  Analysis of nail tissue was also a favorable alternative to blood 
and urine as it is minimally invasive to the test subjects and can be used to analyze other 
cumulative metal levels as well, such as Cu, Fe, Zi, Pb and CrIII.7, 8, 11, 12  
 
Nail clippings are collected from test subjects throughout The Wabash Study.  Before 
analysis clippings are cleaned thoroughly by using a specific cleaning protocol (similar to 
the one used by Grashow’s group) and then chemically digested via a specific digestion 
protocol (see Appendix A).  This is followed by sample preparation and dilution prior to 
analysis via ICP-MS in order to determine the metal concentration levels of the toenail 
tissue.  Due to the nature of toenail growth, the Mn concentration of the actual tissue 
sample (coming from the tip, representing the oldest toenail growth) corresponds to nail 
growth during the time window of exposure approximately 7-12 months prior to the nail 
clipping. Mn nail concentration is obtained for each subject which is then compared to air 
sampling and exposure modeling.  The Wabash Study has found that toenail Mn 
concentration (in µg/g) is highly correlated to the 7-12 months exposure window 





CHAPTER 2.  SPECIFIC AIM, HYPOTHESES, AND OBJECTIVES 
2.1 Specific Aim 
The principal goal of this thesis research is to determine the efficacy of the nail tissue 
cleaning method utilized previously in The Wabash Study.  A significant degree of 
concern has arisen in the research community that significant exogenous contamination 
of welding fume particulates remains on welder subject nail tissue after collection. Thus 
there is concern that this external contamination, containing various welding fume related 
metals, is not entirely removed via the ultrasonic/surfactant based cleaning and purified 
water rinse method employed in The Wabash Study.  As this tissue cleaning method is 
also one commonly used by researchers studying the use of nail tissue as a biomarker for 
welding fume related manganese exposure the present experiment will shed light on the 
validity of previous studies’ results.11 
 
The various objectives of this study all revolve around this central goal of determining 
the validity of the general nail cleaning methodology.  For the sake of simplification due 
to time and logistic concerns, manganese will be the sole element of concern throughout 
this study.  To assist comprehension of the nature of the hypotheses relevant to the 
experimental design, a schematic hypothesis flow diagram is shown in 
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Figure 2-1 which depicts the flow from nail tissue samples, through the experimental 








While the relationship of Hypothesis 1 to the difference between the W-EU and W-EC 
groups is fairly straightforward, it will be helpful to clarify the relationship of Hypotheses 
2 and 3,listed below,  relevant to the difference of means between treatment groups UU 
& EU and UC and EC respectively.  To do this a set of variables is set up as follows: 
ENV = Environmental Mn on control nail 
BIO = Endogenous bio-metabolized Mn incorporated in the nail tissue 
WF = Intentional GMAW WF Mn contamination 
WF_Residual = Residual GMAW WF Mn remaining on nail after cleaning 
 
Using these variables the constituents of the total Mn level for each group can be 
depicted as:  
UC = BIO 
UU = BIO + ENV 
EU = WF + ENV + BIO 
EC = WF_Residual + BIO 
 
Therefore, the comparison of EU to UU should determine if significant contamination is 
being achieved by the WF contamination method to be employed in this study, as will be 
utilized in Hypothesis 2.   
 
Also, the comparison of EC and UC should determine if significant contamination 
remains on the nail tissue after the cleaning protocol has been employed, allowing the 
analysis of Hypothesis 3. 
 
In addition, the relative cleaning efficiency can be determined by comparing the total 
welding fume contamination level to the welding fume residual level.  These values can 




EU - UU = (WF + ENV + BIO) - (BIO + ENV) = WF 
and  
EC - UC = (WF_Residual + BIO) - (BIO) = WF_Residual 
From there it is a simple progression to determining the welding fume concentration 
removed divided by the total welding fume contamination (WF - WF_RESIDUAL / WF) 
to get the removal efficiency. 
(EU - UU) - (EC - UC ) / (EU - UU) = removal efficiency 
  
2.2 Primary Objectives  And Central Hypotheses 
2.2.1 Objective 1: Exogenous Mn contamination to welder fingernail 
The initial objective of this study is to determine the level of exogenous Mn exposure on 
welder fingernail tissue collected from a selection of The Wabash Study’s welder 
subjects to get an idea of upper level of potential exogenous Mn exposure which welder 
subject nail samples may exhibit.  Knowledge of a reasonably approximate upper level of 
exogenous welding fume Mn contamination will allow an attempt to set the intentional 
welding fume Mn contamination of fingernail tissue at a realistic level to provide 
significant contamination without unreasonably overwhelming the cleaning method’s 
ability to remove exogenous Mn.  The presence of significant exogenous Mn 
contamination to nail tissue, if determined, will be evidence of the necessity of an 
efficacious and reliable tissue cleaning method. 
 
Hypothesis 1: Welder subject nail tissue, prior to cleaning, contains a significant quantity 
of exogenous manganese from welding fume exposure. 
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2.2.2 Objective 2: Verification of contamination method 
After the determination is made as to a reasonable value of exogenous Mn contamination 
from welding fume from Objective 1, the necessary apparatus and methodology for 
application of Mn welding fume contaminant deposition must be designed and tested to 
ensure nail tissue Mn contamination at an appropriate level necessary for further analysis 
of the effectiveness of the nail tissue cleaning method.  Additionally, lab sample 
preparation methods must be designed in order to identify proper nail digestion sample 
dilution protocols to ensure proper analysis and analytical equipment safeguarding.  For a 
detailed explanation of the serial dilution steps performed see Appendix A: Nail 
Digestion and ICP-MS sample Protocol.  
 
Hypothesis 2:  Intentional exposure to GMAW welding fume, within the set experimental 
design, will result in significantly higher external contamination levels of 
Mn on the Exposed/Uncleaned fingernails when compared to 
Unexposed/Uncleaned fingernails. 
 
2.2.3 Objective 3: Nail cleaning method validity testing 
Once the proper exposure level and sample dilution levels are determined, the heart of 
this study will be addressed.  Comparison of nail tissue samples from the control subject 
with exogenous exposure of GMAW welding fume and unexposed nail tissue from the 
control subject, will have the current cleaning protocol performed on them prior to 
digestion and analysis for total nail tissue Mn concentration.  The exposed cleaned nail 
tissue is presumed to incorporate the residual welding fume contamination after the 
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cleaning plus the endogenous nail Mn.  The unexposed cleaned nail tissue is presumed to 
only reflect the endogenous nail Mn. The data will be analyzed to determine if there is 
statistical difference between the means of these two treatment groups.  Rejection of 
Hypothesis 3 indicates that some residual welding fume Mn remains after cleaning. 
 
If residual welding fume Mn contamination remains the data will be analyzed to 
determine the fraction of the original contamination level which the residual represents, 
thus the level of effectiveness of the cleaning method to remove exogenous welding fume 
Mn contamination.  If it is possible to show that significantly high levels of external Mn 
contamination can be satisfactorily removed prior to nail tissue digestion and analysis, 
then the use of nail tissue as a viable biomarker will be supported and validated for 
welding fume exposure studies as well as for other settings such as child and 
environmental exposure epidemiological studies. 
 
Hypothesis 3: There is no difference between population means of nail tissue Mn 
concentration after the current cleaning protocol for nail tissue 
significantly contaminated with GMAW welding fume and untreated nail 
tissue cleaned by the same process.   
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CHAPTER 3. METHODOLOGY 
3.1 GMAW Welding Fume As Mn Contaminant 
Actual welding fume was chosen as the contaminant for this study in order to provide 
significant and realistic Mn external exposure to nail tissue.  Other options considered 
were suspended solutions of precipitated welding fume particulates and manganese 
chloride solutions.  These alternatives were rejected due to the fact that they are not true 
representations of the actual exposure to which welding workers’ nail tissue are exposed.  
Manganese (II) chloride is not in the same oxidative state and chemical species as 
manganese in GMAW welding fume, primarily Manganese (II, III) Oxide 17 (Mn3O4 
sometimes written MnO.Mn2O3), a compound formed when manganese is heated in air 
above 1000 °C 18 well below the 6000-8000 °C temperatures of a typical GMAW weld 
arc.19  Precipitated welding fume, like many typical sub-micron particulates, tend to 
agglomerate and aggregate over time and any later suspension of this material would not 
be likely to form deposition on nail tissue as true welding fume does. Chung, in his 
experiments on welding fume air sampling, showed that penetration of welding fume 
through porous foam samplers dropped off as much as 55% after just 4 minutes of 
welding fume aging, an indication that considerable aggregation was taking place over 
time and that aged fume is likely to change significantly in respect to its chemical and 
physical properties.20  It is therefore felt that the extraneous variables introduced by 
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the use of either of the proposed alternatives would be of substantial detriment to the 
internal validity of this study. 
 
Consequently, with the decision to utilize actual welding fume for this study, it became 
necessary to design a welding fume contamination vessel and develop a contamination 
method that is as uniform and as repeatable as possible. The welding used for 
contamination purposes in this study, GMAW, employs a similar welding technique and 
material as The Wabash Study’s worker cohort which predominantly uses GMAW 
welding processes.  GMAW, sometimes referred to as Metal Inert Gas (MIG), utilizes an 
electric arc with mild steel solid core wire and an inert shielding gas, thus avoiding the 
use of flux core wires.  This typically results in superior welds and eliminates the need 
for flux on the substrate or in the wire which characteristically involves greater exposure 
to the welder from Mn fume.21 
 
Upon completion of the GMAW containment vessel design and construction, an initial 
exposure test was performed to determine the duration of weld arc time required to 
provide a significant and realistic level of Mn deposition on the baseline control nails that 
would be similar to the amount of exogenous Mn determined to be on the welder subjects’ 
uncleaned fingernail tissue.  Serial dilutions of the digested nail samples were performed 
on all welding fume exposed uncleaned nail tissue samples in this step in order to 
determine proper dilution levels which would allow proper analysis without endangering 
the sensitive ICP-MS equipment from excessively high Mn concentrations. 
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3.2 Containment Vessel Design 
For this study, a welding fume containment vessel was prepared in order to capture 
generated welding fume and force its precipitation on the cross sectional area of the 
vessel thus allowing sufficient prediction of fume to area deposition onto the exposed nail 
tissue samples.  The vessel consisted of a glass aquarium with glass spatter shield and 
several glass plates to enclose the top of the vessel in order to contain the welding fume.  
The ground clip of the welder unit was run into the vessel and held the carbon steel (mild 
steel) work piece substrate in place facing upward making it easier to weld on while 
allowing minimal open area for the arc gun to enter.  The top of the work piece was kept 
approximately 4 inches below the top glass containment plate, however, in order to 
minimize risk of the excessive heat generated during welding to weaken and crack the 
glass plate.   
 
Multiple glass containment plates were placed on either side of a vertically placed glass 
spatter shield in order to seal the top portion of the vessel.  The spatter shield eliminated 
the possibility that welding spatter would excessively contaminate the nail tissue samples 
beyond the level required and which could pose a threat to the analytical equipment later 
on.  Once the set arc time was completed and the fume had been produced in the arc side 
of the vessel, the arc gun was removed and the opening was closed.  At this time the 
spatter shield was carefully pulled up from between the top glass covers and as it was 
removed the covers were slid together and the glass seam was covered with another plate 
of glass, effectively capturing the fume and allowing it to disperse uniformly throughout 
the vessel.  The fume was allowed to precipitate uniformly and undisturbed for a period 
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of two hours prior to the tissue samples being removed and carefully sealed in plastic 
containers for further sample preparation. The vessel dimensions are 10”W x 20”L x 
11”H and the volume is 1.273 ft3.  Figure 3-1 below depicts the design elements of the 
welding fume containment device.  Photographs of the device and actual application of 
the welding fume contamination process are found in Appendix B. 
 
 
Figure 3-1 Welding Fume Containment Vessel Design 
 
3.3 Welding Equipment 
The welding device used in the study was a Century 100 Wire Feed Welder Model 117-
050 (120V, 30-100A range).  The rated DC output of that model is 85A and 18V and the 
duty cycle is 20%.  For this study the Wire Feed speed selector was set to 4 and the Heat 
selector set to 4.  The approximate wire speed was 12 fpm or about 61 mm/s. 
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The welding wire used was solid core Lincoln Superarc L-56 MIG (GMAW) wire with a 
wire diameter of 0.025”.  This is a copper coated (for tip protection) wire similar to the 
wires used by welder subjects in The Wabash Study.  The AWS ER70S-6 Mn 
requirements for this wire are 1.40 – 1.85 % Mn and the typical range provided by the 
manufacturer is 1.42 – 1.65% Mn.  As GMAW requires shielding gas, argon/CO2 inert 
shielding was supplied via the arc gun to the arc point at a rate of 15 cfh. Shielding gas 
for this study was acquired from Praxair, Lafayette, IN.  
 
3.4 Experimental Design 
With the exception of the welder subject nail tissue which was analyzed to test 
Hypothesis 1 under Objective 1, the rest of this study was a within subject design as all 
the nails for treatment groups UU, EU, UC, and EC came from a single control subject..  
This was chosen to increase the sensitivity of the experimental design, making it more 
likely that small differences in the treatment conditions would be detected.  Left and right 
fingernail sample pairs from the same subject were used as a paired units for comparison 
of the independent variables. Additionally, while the welder nail Mn concentrations may 
have a non-normal distribution, due to unknown fluctuations in their occupational 
exposure levels, it is fairly reasonable to assume that the nail tissue Mn concentrations of 
the single control subject, used for the rest of the study, have a normal distribution, 
allowing easier and more reliable statistical analysis of the small data sample sizes. This 
assumption relies on the facts that the control subject had not obvious occupational or 
environmental Mn exposure, lived and worked in the same locations throughout the 
growth periods of the tissue collected, and did not significantly alter his diet throughout 
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the study.  There is no known reason why the control subjects nails would skew in either 
direction from the mean Mn concentration over the course of tissue collection and nail 
growth relevant to this study. 
 
This study’s single control subject was a non-smoking white male, age 43, with no Mn 
associated health problems and no previous history of welding or any Mn exposure 
associated occupation.  The nail samples from the control subject were acquired between 
November 6, 2013 and May 12, 2014. 
 
3.4.1 Welder Fingernail Analysis 
One reason for using fingernail tissue for Objective 1 was that all the toenail samples so 
far collected during The Wabash Study had already been cleaned and digested for 
analysis to collect data for The Wabash Study.  Another reason was that while welders’ 
toenails are somewhat protected from welding fumes, being inside socks and boots 
during the exposure period, fingernails are much less protected and typically in closer 
proximity to the welding arc.  While welders typically wear protective gloves during the 
act of welding, they routinely remove the gloves throughout the work shift, exposing the 
fingernail tissue to the ambient Mn from welding fume mixed into the work area air.  Not 
all welder subjects were able to provide fingernail tissue samples, but of the welding 
subjects that supplied ample fingernail tissue for analysis, the welding subjects that 
previously showed the highest toenail Mn concentration were selected in order to 
determine the exogenous Mn contamination from welding fume which represents the 
higher end of the exogenous exposure range. 
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Welder subjects WW-10, WW-13, WW-15 and WW-17 were chosen for this analysis. 
Demographics and toenail Mn concentration for the selected welders are shown in Table 
3-1 below.  For the purpose of this study the welder fingernails were considered as an 
exposed treatment group due to their occupational exposure to welding fume.  Half of 
each pair of fingernail sample was left uncleaned prior to digestion (Exposed/Uncleaned 
or EU) and the other half was cleaned via the current cleaning method (Exposed/Cleaned 
or EC).  Samples were digested according to current protocol and ICP-MS analysis was 
run on sample dilutions concurrent with standard spike additions for concentration 
calibration and blanks to subtract instrument background noise. WW-13 and WW-15 
samples were run during the Round 1 samples group while WW-10 and WW-17 samples 
were run during the Round 3 samples group.   
 
Table 3-1 Demographics and toenail Mn concentration for selected welders subjects 




WW10 4/6/2013 white Male 42 12.25 no 9.18 
WW13 7/27/2013 white Male 53 23 no 12.86 
WW15 8/10/2013 Hispanic Male 44 15 no 11.02 
WW17 10/13/2013 African American Male 29 3.5 no 13.90 
 
 
Nail tissue sample Mn concentrations were determined and the difference between the 
welder EU and the welder EC results are the level of exogenous Mn from GMAW 
welding fume present on the welder subjects’ fingernail tissue.  
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3.4.2 Cleaning Protocol 
The Wabash Study cleaning protocol subsists of a surfactant solution assisted by 
ultrasonic cleaning.  Ultrasonic assisted cleaning works via cavitation action at substrate-
cleaning solution interface.  For a detailed description of the cleaning protocol see 
Appendix A section 1.  All DDI water used for cleaning and sample/standard/spike 
preparations had a conductivity of between 13.4 – 13.8 µΩ.  Below is a brief synopsis of 
the cleaning protocol.  
 
• Toenail sample immersed in 10 mL of 1% Triton X-100 solution  
• Samples placed in Branson Sonifier ultrasonic cleaner (400W - 27000Hz) for 15 
minutes at 50% power  




3.4.3 Experiment Round 1 Design 
This round was designed to test the equipment design, determine proper arc time of 
exposure, and begin obtaining data for Objectives 1 through 3.  During this step, four 
pairs of the control subject’s fingernails were prepared and analyzed.  Two pairs were 
split into Unexposed/Uncleaned (UU) and Exposed/Uncleaned (EU) treatment groups.  
The other two pairs were split into Unexposed/Cleaned (UC) and Exposed/Uncleaned 
(EU) treatment groups.  The exposed samples were exposed incrementally to 
successively higher levels of welding fume by running progressively longer periods of 
arc time within the containment vessel for each exposed sample, producing more fume 
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which deposited on the nail tissue sample.  The first half of the welder subject nails 
previously discussed were analyzed as part of Round 1 as well. 
 
3.4.3.1 Estimating required mass of GMAW WF for initial contamination 
As this step was run concurrent with the first objective step, due to time constraints, an 
estimated contamination rate needed to be determined as a starting point of exposure.  
Once the estimated preferential arc time was determined arc times of 0.1x, 1x, 10x, and 
20x were run as the exposures in order to increase the likelihood of finding the 
appropriate exposure window which would allow significant and realistic exposure.   
 
It has previously been determined that welding fume particulate is predominantly 
generated from the welding wire and not the substrate (due to the positive charge polarity 
at the wire) thus the wire itself was of concern in determining the estimated arc time for 
proper contamination.17  Carpenter, et al., determined that GMAW welding fume consists 
of 8.3 % Mn3O4 ; 91.7% Fe3O4 with trace levels of Si and other elements.17  This analysis 
of GMAW fume will be used for the purposes of this study.  
 
Quimby, et al., using similar GMAW methods as this study and a solid core mild steel 
wire with diameter width of 0.045”, predicted for low voltage and amperage similar to 




The starting point to determine an appropriate contamination level was the determination 
of theoretical amount of Mn in a fingernail sample.  It was determined that the average 
Mn concentration in The Wabash Study welder subjects toenail tissue was 8.25 µg/g Mn 
however the highest concentration found in a welder subject toenail tissue (24.9 µg/g Mn) 
will be used as a worst case estimate.  The average weight of toenail samples was 93.2 
mg. The expected typical weight of fingernail sample is half of that weight (46.6 mg).  
Though fingernails typically grow about twice as fast as toenails and thus typically have 
about half the concentration of Mn, the 24.9 µg/g Mn estimate will be used as a liberal 
estimate.  Thus the estimated amount of Mn in a welder subject fingernail sample is 24.9 
µg/g X 46.6 mg = 1.16 µg. 
 
In order to determine the deposition on a fingernail sample from the generated welding 
fume, the ratio of fingernail surface area relative to the cross section area of the floor of 
the containment vessel was required. An estimation of the surface area of a fingernail 
sample was made based on the measurements found in Table 3-2 taken from a typical 
sample of fingernail tissue from the study’s control subject. 
 
The combined surface area of one hand’s fingernail sample is 179 mm2. For a liberal 
estimate of the deposition of welding fume to the nail sample it was assumed that 
gravitational and electrostatic deposition would occur across all but the one down side 
which rests on the floor of the vessel.  The orientation of the nails in on the floor of the 
containment vessel was such that the smallest were never actually the down side.  The 
remaining four sides were averaged and the average was subtracted from the total surface 
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area to represent the area of deposition. Thus the actual exposed surface area of 
deposition is assumed to be 75.7% or 135.5 mm2. 
 
Table 3-2 Estimation of fingernail sample surface area 
 Thumb Index Middle Ring Pinky 
Height (mm) 0.5 0.5 0.5 0.5 0.5 
Length (mm) 1.0 1.0 1.0 1.0 1.0 
Width (mm) 17.0 10.0 12.0 11.0 8.0 
Area (mm2) 52 31 37 34 25 
 
 
In order to ensure the external Mn contamination was significantly higher than the bio-
metabolized Mn in the nail tissue, the amount of Mn in a welder subject fingernail 
estimated above was multiplied by a factor of 2.5.  The actual excess of Mn from 
exposure to welding fume is more likely to be 25 times higher than the control subject’s 
nail concentration as the control subject’s unexposed uncleaned nail Mn concentration is 
expected to be about a tenth that of the uncleaned welder subject’s.  The estimated 
amount of Mn in a welder subject fingernail is 1.16 µg, based on half of the average 
toenail Mn concentration of welders in The Wabash Study cohort, thus the target external 
contamination amount will be 2.90 µg Mn onto the surface areas of the nail sample.  The 
welding fume external contamination is expected to pose little change in the overall 
tissue sample weight thus this should equate to a minimum of 2.5 times increase in nail 
tissue concentration seen upon digestion and analysis. 
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Based on the estimated deposition area of the nail sample and the target contamination 
concentration amount the target mass of deposition per unit area was: 
 
 2.90 µg Mn / 135.5 mm2 = 0.0214 µg/mm2 Mn  
 
The assumption was made that all generated welding fume precipitate deposits equally 
upon the settling area of the chamber (254mm * 508mm = 129,032 mm2), thus the total 
fume generation required was: 
 
 129,032 mm2 * 0.0214 µg/mm2 Mn = 2761.3 µg = 2.76 mg Mn 
 
The chief constituent of Mn in GMAW WF, Mn3O4, is 72% Mn, thus the required mass 
of Mn3O4 was: 
 
2.76 mg Mn / .72 Mn = 3.833 mg Mn3O4 
 
Based on Carpenters work17, assuming GMAW WF is 8.3 % Mn3O4, the required mass of 
GMAW WF would be: 
 
3.833 mg Mn3O4 / 0.083 Mn3O4/WF =  46.18 mg GMAW WF    
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3.4.3.2 Determining the required GMAW arc time for initial contamination  
According to research performed by Quimby7, GMAW WF generation rate, for similar 
voltage, amperage as this study, range approximately around 0.2 - 0.4 g/min arc time.  
However Quimby was using 0.045" diameter wire.  The wire used in this study was  
0.025" diameter which is approximately 26.4% of the cross-sectional area of the wire 
used in Quimby’s study.  Therefore it was estimated that the GMAW WF generation rate 
for this study’s setup and wire was likely in the range of 0.05 - 0.10 g/min arc time. 
Thus in order to achieve the target amount of welding fume particulate to be contained 
and precipitated in the vessel, the total arc time needed was: 
 
0.0462 g GMAW WF / 0.075 g/min arc time = 0.616 minutes arc time (~ 37 sec.) 
 
In order to expand the window of concentration for the welding fume exposure range 
finding test, exposure runs were made at approximately the target arc time, one tenth 
target time, ten times target time and 20 times target time (4, 40, 400, and 800 seconds 
arc time). 
 
3.4.3.3 Prediction of C / Cmax based on steady-state build up 
As the welding performed in this experiment was GMAW, which requires shielding gas 
flowing to the arc tip, and the welding fume containment vessel was of small, finite 
volume, it was necessary to determine whether the arc times listed above would approach 
the steady state system caused by the forced gas flow to the vessel.  The volume of the 
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vessel (V) was 1.27 ft3 and the flow (Q) of shielding gas was 15 ft3/hr = 0.25 cfm at 
constant arc.  The residence time (τ) = V/Q = 5.08 min.  The rate constant (k) therefore 
was 1/τ = 0.197 min-1.  
According to the exponential growth equation, relevant to build-up phase, one can 
determine the proportion of the steady state concentration (Cmax) achieved at each of the 
arc dwell times previously listed as follows: 
C / Cmax = (1 – e-kt)    
Thus the following levels of C / Cmax were determined for each of the assigned arc dwell 
times; 
 
For 4 seconds (0.067 min)    C / Cmax = 0.013         (1.3% of Cmax) 
For 40 seconds (0.667 min)    C / Cmax = 0.123 (12.3% of Cmax) 
For 400 seconds (6.667 min)   C / Cmax = 0.731 (73.1% of Cmax) 
For 800 seconds (13.333 min) C / Cmax = 0.928 (92.8% of Cmax) 
 
Based on these calculations a nearly 10 fold increase in exposure should exist between 
the 4 and 40 second arc time exposures while the jump to 400 seconds and 800 seconds 
would only be 6 times and 1.25 times the previous arc time exposure respectively.  It was 




An assumption was made based on the C / Cmax calculations above, to estimate that the 4 
and 40 second arc times would be relatively close to the estimated target contamination 
levels but that the 400 and 800 arc times would lead to 6 and 7.5 times the 40 sec arc time 
level respectively.   
 
3.4.4 Round 1 ICP-MS preparations and estimated Mn concentrations  
Table 3-3 and Table 3-4 below describe the Round 1 sample identification and sample 
preparations for ICP-MS analysis respectively, which include both Objective 1 and 
Objective 2 samples.  In order to protect the ICP-MS equipment serial dilutions were 
made of the welding fume exposed sample preparations.  For each subsequent order of 
magnitude serial dilution the initial stock solution was diluted to one tenth of the previous 
stock solution.  These serial diluted stock solutions were then used to prepare sample 
preparations.  For example, the sample 1-2 stock solution was diluted to 0.1 concentration 
and labeled as the 0.1 dilution stock solution for sample 1-2 and the sample 1-2B ICP-MS 
sample preparation was prepared from that stock solution.  The 0.1 dilution stock solution 
for sample 1-2 was then diluted to one tenth (0.01 concentration of the original stock 
solution) and the sample 1-2C ICP-MS sample preparation was prepared from that stock 
solution and so on.  The serial dilutions were annotated with a letter suffix attached to the 
sample number B being prepared from a 0.1 dilution stock solution, C from a 0.01 stock 
solution, etc.   
 
Analytical chemists were instructed as to the nature of the estimated Mn ppb levels and 
the serial dilution order so they could do a pre-run ICP-MS analysis starting with the 
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most dilute sample preparations and moving higher in order to find the appropriate 
dilution level that would give a good reading and yet not harm the equipment.   
 
Table 3-3 Round 1 ICP-MS sample identification 
Sample ID Group Subject  Nail  Collection 
1-1 UU JCB  FL  4/24/2014 
1-2 EU JCB  FR  4/24/2014 
1-3 EU JCB  FL  4/10/2014 
1-4 UU JCB  FR  4/10/2014 
1-5 UC JCB  FL  4/2/2014 
1-6 EU JCB  FR  4/2/2014 
1-7 EU JCB  FL  3/22/2014 
1-8 UC JCB  FR  3/22/2014 
1-9 W-EU WW13  FL  7/27/2013 
1-10 W-EC WW13  FR  7/27/2013 
1-11 W-EC WW15  FL  8/10/2013 
1-12 W-EU WW15  FR  8/10/2013 
 
Once the proper dilution levels were determined for each of the exposed samples a full 
ICP-MS run was done using those dilutions and the sample preparations for the 
unexposed samples.  In this fashion, not all of the sample preparations were actually run 
in the final ICP-MS run as all but one of the serial dilutions for each exposed sample 
were irrelevant at that point. Only samples actually run will be reported in the results 
section. 
 
The expected nail Mn concentration for samples 1 – 8 was approximated at 2 µg/g.  This 
was estimated from a 3.4 µg/g concentration average seen from test subject toenail 
concentration analyzed earlier as part of The Wabash Study, and the fact that toenail  
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tissue typically grows at half the rate of fingernail growth.10  For the purposes here the 
estimation will not be changed.  Samples 9&10 and 11&12 were from welder subjects 
#13 and #15 (of the Wabash Study) respectively.  The expected fingernail concentration 
for each welder subject was determined in a similar fashion using data from their toenails. 
 



























1-1 UU 37.19 2.0 74.4 - 74.4 7.44 1.06 
1-2 EU 47.02 2.0 94.0 290 384.0 38.40 5.49 
1-2B EU “ - - - - 3.84 0.55 
1-2C EU “ - - - - 0.38 0.06 
1-3 EU 37.34 2.0 74.7 2900 2975.0 297.50 42.50 
1-3B EU “ - - - - 29.75 4.25 
1-3C EU “ - - - - 2.98 0.43 
1-3D EU “ - - - - 0.30 0.04 
1-4 UU 22.03 2.0 44.1 - 44.1 4.41 0.63 
1-5 UC 37.48 2.0 75.0 - 75.0 7.50 1.07 
1-6 EU 37.16 2.0 74.3 17235 17309.0 1731.00 247.00 
1-6B EU “ - - - - 173.10 24.70 
1-6C EU “ - - - - 17.310 2.47 
1-6D EU “ - - - - 1.73 0.25 
1-6E EU “ - - - - 0.17 0.03 
1-7 EU 30.58 2.0 61.2 21544 21605 2161.00 309.00 
1-7B EU “ - - - - 216.10 30.90 
1-7C EU “ - - - - 21.610 3.09 
1-7D EU “ - - - - 2.16 0.31 
1-7E EU “ - - - - 0.22 0.03 
1-8 UC 25.97 2 51.9 - 51.9 5.19 0.74 
1-9 W-EU 60.33 6.4 388 - 388 38.80 5.54 
1-10 W-EC 30.06 6.4 193 - 193 19.30 2.76 
1-11 W-EC 59.72 5.5 329 - 329 32.90 4.70 
1-12 W-EU 30.66 5.5 169 - 169 16.90 2.41 
 
 
For this study the Sample-ID of the control subject samples are listed as the Round No. – 
Sample No., sometimes followed by the abbreviation of the treatment group (UU, 
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UC..etc.) for clarity.  The GMAW welding fume exposed samples were Sample 1-2 (4 
sec. arc time WF generation exposure), Sample 1-3 (40 sec.), Sample 1-6 (400 sec.), and 
Sample 1-7 (800 sec.).  The welder subject nail samples were also considered exposed, 
for the purpose of this study, but were not intentionally exposed to additional welding 
fume during this study.   
 
It must be noted that upon finishing the 800 second arc time run and removing the spatter 
shield, the seal was broken on the top of the vessel and some fume escaped before it 
could be resealed.  This was expected to result in a contamination level for that sample 
significantly less than expected.  Also the expected concentrations for the uncleaned 
welder subject fingernails do not take into account any external Mn contamination.  It is 
assumed there is contamination but at the time of analysis there was no way of predicting 
the level. 
 
Standard spike additions were made using the sample 5 stock in order to preserve the 
matrix effects of nail keratin constituents, present in all other sample preparations, along 
with the standard addition preparations for use in determining a calibration curve from 
the ICP-MS analysis data.  Additions were prepared from Exaxol multi-element standard 
which resulted in standards spikes of sample 5 sample preparations at +1.43 ppb, + 4.29 
ppb, + 7.15 ppb, + 14.3 ppb, and + 28.6 ppb Mn.  Blank sample preparations were also 
prepared to be run during the ICP-MS run and all sample preparations including the serial 
dilution sample preparations were maintained at 2% nitric concentration using ultrapure 
trace element analysis grade nitric acid. 
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ICP-MS data was collected from the Round 1 analytical run and used to help determine 
the results of Objective 1 and 2 and to determine the exposure level for further rounds of 
welding fume contamination samples for evaluation of Objectives 2 and 3. 
 
It was predicted that since this subject was a control (at the time of tissue collection) that 
the UU and UC tissue Mn concentrations would be significantly similar and that all EU 
samples regardless of arc time of exposure, would have significantly higher Mn 
concentration resulting from the uncleaned external welding fume exposure. 
 
3.4.5 Experiment Round 2 Design 
Once the Round 1 samples were analyzed, a contamination per arc time curve was 
prepared (see figure 4-2) in order to attempt to match a specific arc time exposure to a 
reasonable contamination level based on the exogenous Mn level seen on the welders nail 
tissue.  At that point, once the proper exposure level is determined, Round 2 was initiated 
to continue deriving data for Objective 2 as well as to begin obtaining data for Objective 
3.  Within-subject and within-group pairs of the control subject’s fingernails (left and 
right samples maintained separately) were split into separate treatment groups. Half of 
each pair was exposed and cleaned using The Wabash Study cleaning protocol and the 
other half unexposed and cleaned via the same method.  In this manner the efficacy of the 
cleaning method will be tested.  Once the four pairs of the EC/UC combinations from 
Round 2 were run and analyzed, statistical tests were performed in order to determine the 
number of additional samples needed to be run in the same fashion (during Round 3) in 
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order to define with statistic validity whether the exogenous contamination is being fully 
removed by the cleaning method. (Objective 3)  
 
Additional sets of fingernails were run with half of the pair exposed to GMAW fume and 
left uncleaned (EU) to be compared to the unexposed and uncleaned half of the pair (UU) 
in order to validate the actual exposure level of the particular round of exposure.  This 
was necessary due to the marginal control over the actual welding fume exposure 
generation available with the welding device, and the need to assure each round of 
exposures received an adequate and reasonable level of contamination.   
 
Samples were analyzed via ICP-MS in a similar fashion as in Round 1.  To be sure that 
the Exposed/Uncleaned (EU) sample preparations would not damage ICP-MS equipment, 
serial dilutions were again run on Round 2 samples.  Additionally in order to be sure that 
failure of the cleaning method does not result in Exposed/Cleaned (EC) samples 
remaining at too high a concentration for the ICP-MS equipment, one set of serial 
dilutions for a particular Exposed/Cleaned (EC) sample was also be prepared and 
analytical chemists were instructed on the nature of all samples. 
 
Table 3-5 and Table 3-6 below describe the Round 2 sample identification and sample 
preparations for ICP-MS analysis respectively, which include both Objective 2 and 
Objective 3 samples.  The same digestion and sample preparation protocol along with 
spikes, blanks, and necessary serial dilutions were performed as in Round 1. Only 
samples actually run will be reported in the results section. 
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The estimation of the control subject’s nail tissue concentration was adjusted to 0.2 µg/g 
Mn after analysis of Round 1 data indicated the error in the initial estimate.  The 
estimated deposition mass of WF Mn contamination to the exposed Round 2 samples was 
derived from the estimated WF Mn concentration for the arc time used in Round 2 based 
on the analysis of the concentration range by arc time analysis performed on the Round 1 
data (see Figure 4-2).  For a detailed explanation of how the estimation was derived as 
well as why the particular arc time was chosen for Round 2 exposure, see section 4.1.  
 
Table 3-5 Round 2 ICP-MS sample identification 
Sample ID Group Subject Nail Collection 
2-1 UU JCB FL 3/10/2014 
2-2 EU JCB FR 3/10/2014 
2-3 EU JCB FL 2/28/2014 
2-4 UU JCB FR 2/28/2014 
2-5 UC JCB FL 2/16/2014 
2-6 EC JCB FR 2/16/2014 
2-7 EC JCB FL 2/2/2014 
2-8 UC JCB FR 2/2/2014 
2-9 UC JCB FL 1/26/2014 
2-10 EC JCB FR 1/26/2014 
2-11 EC JCB FL 1/13/2014 
2-12 UC JCB FR 1/13/2014 
 
3.4.6 Experiment Round 3 Design 
Once the Round 2 samples were analyzed and descriptive statistics and confidence 
intervals were identified for the treatment group comparisons associated to Hypotheses 2 
and 3, Round 3 samples were prepared and run based on the estimations of required 
sample sizes needed based on the pooled data from Round 1 and Round 2.  Again, similar 
UU/EU samples were prepared to determine the absolute contamination level of the 
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Round 3 contamination and similar ICP-MS analysis was performed with serial dilutions 
as mentioned above. 
 



























2-1 UU 33.38 0.20 6.68 - 6.68 0.67 0.10 
2-2 EU 32.52 0.20 6.50 1300.80 1307.30 130.73 18.68 
2-2B EU " - - - - 13.07 1.87 
2-2C EU " - - - - 1.31 0.19 
2-3 EU 31.92 0.20 6.38 1276.80 1283.18 128.32 18.33 
2-3B EU " - - - - 12.83 1.83 
2-3C EU " - - - - 1.28 0.18 
2-4 UU 38.37 0.20 7.67 - 7.67 0.77 0.11 
2-5 UC 34.25 0.20 6.85 - 6.85 0.69 0.10 
2-6 EC 37.82 0.20 7.56 - 7.56 0.76 0.11 
2-6B EC " - - - - 0.08 0.01 
2-7 EC 29.08 0.20 5.82 - 5.82 0.58 0.08 
2-7B EC " - - - - 0.06 0.01 
2-8 UC 26.63 0.20 5.33 - 5.33 0.53 0.08 
2-9 UC 31.35 0.20 6.27 - 6.27 0.63 0.09 
2-10 EC 36.56 0.20 7.31 - 7.31 0.73 0.10 
2-10B EC " - - - - 0.07 0.01 
2-11 EC 33.03 0.20 6.61 - 6.61 0.66 0.09 
2-11B EC " - - - - 0.07 0.01 
2-12 UC 37.22 0.20 7.44 - 7.44 0.74 0.11 
 
Table 3-7 and Table 3-8 below describe the Round 3 sample identification and sample 
preparations for ICP-MS analysis respectively, which include samples to obtain data for 
Objectives 1 through 3.  Only samples actually run will be reported in the results section.  
For an explanation of how the estimated deposition mass of WF Mn contamination to the 
exposed Round 3 samples was derived, see section 4.2. 
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Table 3-7 Round 3 ICP-MS sample identification 
Sample ID Group Subject Nail Collection 
3-1 EU JCB FL 5/12/2014 
3-2 EU JCB FR 5/12/2014 
3-3 EU JCB FL 1/2/2014 
3-4 UU JCB FR 1/2/2014 
3-5 UU JCB FL 12/24/2013 
3-6 EU JCB FR 12/24/2013 
3-7 EC JCB FL 12/11/2013 
3-8 UC JCB FR 12/11/2013 
3-9 UC JCB FL 11/30/2013 
3-10 EC JCB FR 11/30/2013 
3-11 EC JCB FL 11/19/2013 
3-12 UC JCB FR 11/19/2013 
3-13 UC JCB FL 11/6/2013 
3-14 EC JCB FR 11/6/2013 
3-15 W-EC WW10 FL 4/6/2013 
3-16 W-EU WW10 FR 4/6/2013 
3-17 W-EU WW17 FL 10/13/2013 
3-18 W-EC WW17 FR 10/13/2013 
 
3.5 ICP-MS Analysis 
For this study 55Mn ICPMS results were obtained using an ELEMENT-2 
(ThermoFinnigan, Bremen, Germany) mass spectrometer in the medium resolution mode. 
An Aridus desolvating system with a T1H nebulizer (Cetac Technologies, Omaha NE) 
was used to introduce the sample preparations into the plasma which enhances sensitivity 
and reduces oxide and hydride interferences. Argon sweep gas and nitrogen of the Aridus 
were adjusted for maximum peak height and stability using 7Li, 115In and 238U peaks 
obtained from a Merck multi-element standard (1ng/ml, Merck & Co.).  The nebulized 
sample introduced into the high temperature argon plasma (on the order of 10,000°K) 
rapidly desolvates, vaporizes and atomizes.  Mn atoms quickly ionize (near 100% yield) 
as singly charged ions which are detected and analyzed via mass spectrometry.  A 
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discussion of the analysis of MS counts per second 55Mn to calculate the original sample 
concentration of Mn can be found in Chapter 4. 
 


























3-1 EU 31.40 0.20 6.28 320.28 326.56 32.66 4.67 
3-1B EU " - - - - 3.27 0.47 
3-1C EU " - - - - 0.33 0.05 
3-2 EU 42.69 0.20 8.54 435.44 443.98 44.40 6.34 
3-2B EU " - - - - 4.44 0.63 
3-2C EU " - - - - 0.44 0.06 
3-3 EU 30.09 0.20 6.02 306.92 312.94 31.29 4.47 
3-3B EU " - - - - 3.13 0.45 
3-3C EU " - - - - 0.31 0.04 
3-4 UU 25.84 0.20 5.17 - 5.17 0.52 0.07 
3-5 UU 39.74 0.20 7.95 - 7.95 0.79 0.11 
3-6 EU 46.85 0.20 9.37 477.87 487.24 48.72 6.96 
3-6B EU " - - - - 4.87 0.70 
3-6C EU " - - - - 0.49 0.07 
3-7 EC 22.48 0.20 4.50   4.50 0.45 0.06 
3-8 UC 32.11 0.20 6.42 - 6.42 0.64 0.09 
3-9 UC 23.10 0.20 4.62 - 4.62 0.46 0.07 
3-10 EC 35.18 0.20 7.04   7.04 0.70 0.10 
3-11 EC 36.00 0.20 7.20   7.20 0.72 0.10 
3-12 UC 42.44 0.20 8.49 - 8.49 0.85 0.12 
3-13 UC 36.36 0.20 7.27 - 7.27 0.73 0.10 
3-14 EC 44.89 0.20 8.98   8.98 0.90 0.13 
3-15 W-EC 25.67 4.60 118.08 - 118.08 11.81 1.69 
3-16 W-EU 46.90 4.60 215.74 - 215.74 21.57 3.08 
3-16B W-EU " - - - - 2.16 0.31 
3-17 W-EU 118.35 7.00 828.45 - 828.45 82.85 11.84 
3-17B W-EU " - - - - 8.28 1.18 
3-18 W-EC 113.90 7.00 797.30 - 797.30 79.73 11.39 
3-18B W-EC " - - - - 7.97 1.14 
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3.6 Statistical Analysis 
For all nail tissue concentration data collected it was important to establish whether data 
showed a significant deviation from normality. Various statistical methods were 
employed for this purpose.  Typically determination of dataset normality is performed 
using numeric or graphical methods which can be either descriptive-based or theory-
based (hypothesis-based).  Due to the very small sample size of this study’s treatment 
groups, the methods chosen were P-P and Q-Q plots (Theoretical-Graphical), box plot 
(Descriptive-Graphical), skewness and kurtosis (Descriptive-Numerical), and three 
Hypothesis-driven numerical methods, the Shapiro-Wilk, Chi-Square and Anderson-
Darling normality tests.   
 
The Shapiro-Wilk Normality Test was given the most weight in decision making because 
it is appropriate for distribution analysis of groups with small sample sizes like the ones 
in this study and is likely a more truthful representation of the normality of such small 
sample size data than descriptive-based methods listed. The National Institute of Health 
recommends the use of the Shapiro-Wilk Normality Test for sample size of less than 50.  
NIH recommends that one of the most popular normality tests, the Kolmogorov-Smirnov 
 
Test should no longer be used because of its low power in general, especially for sample 
sizes below 50.23  Additional reasoning for the use of particular methods lies in research 
performed by Razali, in which he detailed a comparison of the hypothesis-based 
numerical methods, Shapiro–Wilk, Anderson-Darling, Kolmogorov–Smirnov, and 
Lilliefors.  Razali found that for a given significance level the Shapiro-Wilk Test had the 
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most statistical power.  He found the Anderson-Darling Test to be a close second in the 
running.24  The Chi-Square test for normality, although not a very powerful method, is 
quite useful for very low sample sizes. 
 
If data was found to be normal, 95% confidence limits about the mean for the two groups 
were calculated as well as a Two-group t-test of the difference of means for small sample 
size used to test the hypothesis that the two population means are significantly different.  
For data found to be non-normally distributed, the determination was made that the small 
sample sizes would not enable a clear depiction of the population distributions.  Thus any 
attempt to discern another standard type of distribution would likely yield similar limited 
conclusions do to low statistical power.  It was determined not to normalized the data but 
to instead rely upon non-parametric methods, specifically the Wilcoxon Ranked Sum 
Test and Kruskal-Wallis Test. The non-parametric tests are a more conservative approach 
when dealing with datasets of unknown and differing distribution types. It was assumed 
at the onset of the study that by the nature of the within-subject design for Objectives 2 
and 3, the data acquired from the single control subject nail samples would likely be 
normally distributed.  A schematic flow diagram of the statistical methods used in this 












CHAPTER 4. RESULTS 
4.1 Round 1 Results 
Table 4-1 displays the results of the Round 1 ICP-MS analysis for Mn in the prepared 
samples. The Round 1 blank preparations had an average Mn counts per second (cps) of 
296.4 and this cps value is deducted from the actual cps for each sample in order to 
eliminate the signal noise of the instrument.  It should be noted that, as mentioned in the 
methodology section, the analytical chemists ran serial dilution samples ahead of the 
actual Round 1 ICP-MS run to determine the appropriate serial dilution level to use.  All 
samples chosen for the main run were prepared from the initial stock solution with the 
exception of samples 1-6B and 1-7B which were prepared from 0.1x dilution stock 
solution.  The dilution factor is taken into account before the calculation of the nail tissue 
Mn concentration level. 
 
A calibration curve was prepared based on the ICP-MS cps data from sample 1-5 and the 
four standard addition spikes made with that sample’s stock solution.  Data from the 
spiked samples is seen in Table 4-2 and the Round 1 calibration curve is shown in Figure 
4-1.  The 55Mn (cps) data in Table 4-1 and Table 4-2 already have the average blank cps 
deducted. Figure 4-1 also shows the line equation for the calibration curve.  The slope of 
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the line is used to calculate the sample preparation Mn concentrations.  The Round 1 
calibration slope is 18421 which indicates that every 18421 cps Mn55 equals 1 ng/mL or 
ppb Mn in the sample preparation. From the deduced Mn concentration of each sample 
preparation, a stepwise calculation backward to the actual nail tissue sample Mn 
concentration was performed, taking into account dilution factors when necessary, to 
arrive at the tissue concentration levels seen in Table 4-1.  
 







































1-1 UU 37.19 1838.5 0.10 0.70 0.70 6.99 6.99 0.19 
1-2 EU 47.02 58039.1 3.15 22.05 22.05 220.55 220.55 4.69 
1-3 EU 37.34 142835.2 7.75 54.28 54.28 542.78 542.78 14.54 
1-4 UU 22.03 3789.1 0.21 1.44 1.44 14.40 14.40 0.65 
1-5 UC 37.48 2210.0 0.12 0.84 0.84 8.40 8.40 0.22 
1-6B EU 37.16 55314.9 3.00 21.02 21.02 210.20 2101.97 56.57 
1-7B EU 30.58 31634.4 1.72 12.02 12.02 120.21 1202.11 39.31 
1-8 UC 25.97 1097.1 0.06 0.42 0.42 4.17 4.17 0.16 
1-9 W-EU 60.33 139626.5 7.58 53.06 53.06 530.58 530.58 8.79 
1-10 W-EC 30.06 26075.1 1.42 9.91 9.91 99.09 99.09 3.30 
1-11 W-EC 59.72 52004.6 2.82 19.76 19.76 197.62 197.62 3.31 
1-12 W-EU 30.66 66712.2 3.62 25.35 25.35 253.51 253.51 8.27 
 
Table 4-2  Round 1 ICP-MS Spike Data 
ID Additional ppb Mn55 (cps) Delta cps 
1-5 0 2210.0 - 
1-5 + 1.43 ppb 1.4286 30141.7 27931.7 
1-5 + 4.29 ppb 4.2857 80648.9 78438.9 
1-5 + 7.15 ppb 7.1429 132899.2 130689.2 
1-5 + 14.3 ppb 14.2857 266201.0 263991.0 
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Figure 4-1 Round 1 ICP-MS Calibration Curve 
 
An example calculation of tissue concentration for sample 1-1 is as follows.  The blank 
corrected 55Mn cps (1838.5 cps) divided by the slope of 18421 cps/ppb equals 0.10 ppb 
which is the concentration of the actual 7 mL sample prep.  Multiplying this times 7 mL 
results in a total Mn mass in the sample prep of 0.70 ng.  Since 1.00 mL of the stock 
solution was used to make the sample preparation solution, the stock solution is thus 0.70 
ng/mL.  Multiplying that concentration by the 10 mL of the initial stock solution results 
in 6.99 total ng Mn.  Since the base stock solution was used for sample 1-1 (not a serial 
dilution of the stock solution) no dilution factor was applied.  Since all of the digested 
tissue sample was in the preparation of the stock solution, dividing the total Mn in the 
stock solution by the initial dry tissue sample weight results in final value for tissue Mn 
concentration of 0.19 µg/g (ppm).  
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Figure 4-2 shows a graphical representation of the first three Exposed/Uncleaned samples 
used to test the increase in tissue nail concentration increase with increasing arc time in 
the welding fume containment vessel (arc times 4s, 40s, and 400s).  A steady state build 
up curve is fitted to the data points and shown in Figure 4-2.  The fourth 
Exposed/Uncleaned sample was not used.  As noted early the 800s arc time exposure was 
deemed unusable due to an error in sealing the containment vessel after the welding fume 
was generated, allowing a significant portion of the fume to escape before it could 
precipitate onto the nail tissue.  As predicted the increase of nail Mn concentration from 
the contamination follows a steady-state build up curve due to the flow of shielding gas 
into the containment vessel.  
 
The welder subject fingernail tissue, analyzed in Round 1, exhibited an average of 
approximately 5.25 µg/g Mn, as exogenous Mn contamination. This was presumed to be 
from their occupational welding fume exposure.  To be certain that the contamination of 
the control subject nail tissue in Rounds 2 and 3, for the Exposed treatment groups, was 
contaminated with at least double that level and yet not so high as to overwhelm the 
cleaning protocol, a choice was made to target a nail tissue contamination level of 40 
µg/g Mn as exogenous Mn contamination.  The choice was skewed to the high side as the 
contamination method had an as of yet unproven repeatability and many inputs effect the 
overall generation of welding fume, such as wire speed, proper containment, shielding 
gas flow, etc.  On the GMAW arc time vs. nail Mn concentration chart the arc time which 
corresponds to the 40 µg/g Mn concentration level is approximately 180 seconds.  
Therefore, a 180s arc time was chosen as the exposure level for Round 2. 
49 
 
Figure 4-2 GMAW arc time vs. nail Mn concentration 
4.2 Round 2 Results 
Table 4-3 displays the results of the Round 2 ICP-MS analysis for Mn in the prepared 
samples. The Round 2 blank preparations had an average Mn counts per second (cps) of 
309.4 and this cps value is deducted from the actual cps for each sample in order to 
eliminate the signal noise of the instrument. Chemists ran similar serial dilution samples 
ahead of the actual Round 2 ICP-MS run to determine the appropriate serial dilution level 
to use.  All samples chosen for the main Round 2 run were prepared from the initial stock 
solution with no exceptions. 
 
A calibration curve was prepared based on the ICP-MS cps data from sample 2-5 and the 
five standard addition spikes made with that sample’s stock solution.  Data from the 
spiked samples is seen in Table 4-4 and the Round 2 calibration curve is shown in Figure 
4-3.  The 55Mn (cps) data in Table 4-3 and Table 4-4 already have the average blank cps 
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deducted. Figure 4-3 also shows the line equation for the Round 2 calibration curve.  The 
slope of the line is used to calculate the sample preparation Mn concentrations.  The 
Round 2 calibration slope is 13324 which indicates that every 13324 cps Mn55 equals 1 
ng/mL or ppb Mn in the sample preparation. From the deduced Mn concentration of each 
sample preparation, a stepwise calculation backward to the actual nail tissue sample Mn 
concentration was performed to arrive at the tissue concentration levels seen in Table 4-3. 
Dilution factors were not necessary for analysis of Round 2 data as none of the serial 
dilution samples were used in the main run.  
 


























2-1 UU 33.38 2802.9 0.21 1.47 1.47 14.73 0.44 
2-2 EU 32.52 52173.2 3.92 27.41 27.41 274.10 8.43 
2-3 EU 31.92 73101.5 5.49 38.41 38.41 384.05 12.03 
2-4 UU 38.37 2715.0 0.20 1.43 1.43 14.26 0.37 
2-5 UC 34.25 746.7 0.06 0.39 0.39 3.92 0.11 
2-6 EC 37.82 5782.6 0.43 3.04 3.04 30.38 0.80 
2-7 EC 29.08 2548.5 0.19 1.34 1.34 13.39 0.46 
2-8 UC 26.63 698.6 0.05 0.37 0.37 3.67 0.14 
2-9 UC 31.35 807.3 0.06 0.42 0.42 4.24 0.14 
2-10 EC 36.56 3618.3 0.27 1.90 1.90 19.01 0.52 
2-11 EC 33.03 3179.0 0.24 1.67 1.67 16.70 0.51 
2-12 UC 37.22 760.0 0.06 0.40 0.40 3.99 0.11 
 
The nail tissue Mn concentration of the exposed samples in Round 2 was estimated by 
the average nail tissue concentration of the two Exposed/Uncleaned samples (avg. 10.2 
µg/g Mn).  This was approximately 25.5% of the target concentration of 40 µg/g Mn but 
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still approximately twice the level of the exogenous Mn contamination seen on the 
welder subject nails from Round 1.  The contamination level was deemed acceptable and 
the arc time of 180s was maintained through Round 3. 
 
Table 4-4  Round 2 ICP-MS Spike Data 
ID Additional ppb Mn55 (cps) Delta cps 
2-5 0 1056.1 - 
2-5 + 0.71 ppb 0.7143 11248.4 10192.3 
2-5 + 1.43 ppb 1.4286 19816.3 18760.2 
2-5 + 2.86 ppb 2.8571 37871.4 36815.3 
2-5 + 5.71 ppb 5.7143 75235.9 74179.8 








4.3 Estimation of Required Sample Size  
In order to determine the number of additional samples required in Round 3 to assure 
statistical power in testing the study’s hypotheses, an estimation of required sample size 
was made by pooling the data from Round 1 and Round 2.  All data were pooled except 
the EU samples from Round 1 which were exposure contamination samples done at 
varied arc time in order to estimate arc time versus contamination level and thus were not 
appropriate for comparison to the UU and other EU samples.  An assumption was made 
at this point, because of the very low sample sizes and the fact that σ was not known for 
any of the populations, that the data was approximately normally distributed and the 
Student’s t-distribution should be used.  Descriptive statistics were calculated as well as 
confidence intervals based on the Student’s t-distribution for the various treatment groups.  
The confidence intervals between the treatment groups relevant to each hypothesis were 
compared.  The pooled data are shown in Table 4-5 and the descriptive statistics and 
confidence limits are depicted in Table 4-6 below. 
 
The welder EU and EC treatment groups already had confidence intervals that were 
significantly separated with the EU group much higher in Mn concentration.  This was a 
good indication of validity to hypothesis 1 – that welders do indeed have significant 
exogenous contamination of Mn on their nails which must be removed in order to 
properly interpret nail tissue Mn levels as a biomarker of internalized welding fume Mn 
exposure.  It was decided to go ahead and run two additional welder EU and two welder 
EC samples in Round 3 in order to solidify the statistical power of this assumption.  
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Similarly, the control subject UC versus EC comparison, even at six and four samples 
respectively, already shows significantly separated confidence intervals, indicating failure 
to find validity of hypothesis 3 – that the current cleaning method is capable of removing 
all the exogenous welding fume Mn contamination from the nail tissue.  However, the 
tightness of the confidence intervals and the closeness of the two means is an indication 
that the vast majority of the external contamination is being removed.  Nonetheless, as 
this is the heart of the study, it was decided that four additional samples each of the UC 
and EC treatment groups would be included in Round 3 to improve the statistical power 
of this conclusion. 
 
Table 4-5 Round 1 & 2 pooled data  
Sample 
ID Group Subject Nail 
Tissue conc. 
(ng/mg) or (µg/g) 
1-9 W-EU WW13 FL 8.79 
1-12 W-EU WW15 FR 8.27 
1-10 W-EC WW13 FR 3.30 
1-11 W-EC WW15 FL 3.31 
1-1 UU JCB FL 0.19 
1-4 UU JCB FR 0.65 
2-1 UU JCB FL 0.44 
2-4 UU JCB FR 0.37 
2-2 EU JCB FR 8.43 
2-3 EU JCB FL 12.03 
1-5 UC JCB FL 0.22 
1-8 UC JCB FR 0.16 
2-5 UC JCB FL 0.11 
2-8 UC JCB FR 0.14 
2-9 UC JCB FL 0.14 
2-12 UC JCB FR 0.11 
2-6 EC JCB FR 0.80 
2-7 EC JCB FL 0.46 
2-10 EC JCB FR 0.52 
2-11 EC JCB FL 0.51 
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S SE T95 LCL95 UCL95 E 
W-EU 2 8.531 0.372 0.263 12.706 5.188 11.875 3.344 
W-EC 2 3.303 0.009 0.006 12.706 3.221 3.384 0.081 
UU 4 0.414 0.192 0.096 3.182 0.107 0.720 0.306 
EU 2 10.230 2.548 1.801 12.706 -12.660 33.120 22.890 
UC 6 0.147 0.042 0.017 2.571 0.102 0.191 0.044 
EC 4 0.572 0.156 0.078 3.182 0.324 0.821 0.248 
 
Lastly, the UU and EU treatment groups did have confidence intervals which overlapped, 
however this was chiefly due to the significantly high variance and very low sample size 
of the EU group.  A calculation was made to determine an appropriate number of EU 
samples to run in Round 3 which would be able to clarify the comparison between the 
UU and EU treatment groups.  With the vastly higher mean Mn concentration of the EU 
group, it was clear that the margin of error for the EU group did not need to be contracted 
by much, a margin of error of approximately 3 would already put the UU and EU 
confidence intervals well apart.  The equation for the t-distribution confidence limit is:  
 
The confidence limit is the mean surrounded by the margin of error which is essentially 
the t value, given by the percent confidence desired and the degrees of freedom 
multiplied by the standard error of the mean ( equal to the standard deviation divided by 
the square root of the sample size ). Thus the margin of error is simply:  
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An estimated guess of n=6 leads to a 95% t-value of 2.571 and with the EU standard 
deviation of 2.548 we arrive at: 
 
A margin of error of approximately 2.67 was determined to be more than adequate and 
should leave room for error if the variance of the EU group was to increase somewhat 
even with the larger sample size.  The decision was made to run four additional EU 
samples in Round 3 to bring the total to six.  As the UU group versus EU group 
comparison is required during each run in order to ascertain the actual level of 
contamination for the particular run, an additional two UU samples were also set to be 
run in Round 3.  The set of additional samples run in Round 3 is shown in Table 3-8 
 
4.4 Round 3 Results 
Table 4-7 displays the results of the Round 3 ICP-MS analysis for Mn in the prepared 
samples. The Round 3 blank preparations had an average Mn counts per second (cps) of 
691.2 and this cps value is deducted from the actual cps for each sample in order to 
eliminate the signal noise of the instrument. The Chemists ran similar serial dilution 
samples ahead of the actual Round 3 ICP-MS run to determine the appropriate serial 
dilution level to use.  All samples chosen for the main Round 2 run were prepared from 
the initial stock solution with the exception of sample 3-17B which was prepared from a 
one tenth dilution of the sample 3-17 stock solution. 
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A calibration curve was prepared based on the ICP-MS cps data from sample 3-5 and the 
five standard addition spikes made with that sample’s stock solution.  Data from the 
spiked samples is seen in Table 4-8 and the Round 3 calibration curve is shown in Figure 
4-4.  The 55Mn (cps) data in Table 4-7 and Table 4-8 already have the average blank cps 
deducted. Figure 4-4 also shows the line equation for the Round 3 calibration curve.  The 
Round 3 calibration slope is 47228 which indicates that every 47228 cps 55Mn equals 1 
ng/mL or ppb Mn in the sample preparation. From the deduced Mn concentration of each 
sample preparation, a stepwise calculation backward to the actual nail tissue sample Mn 
concentration was performed to arrive at the tissue concentration levels seen in Table 4-7.  
The one tenth dilution factor for sample 17B was taken into account in the calculation of 
tissue concentration, not other samples required correction. 
 
The nail tissue Mn concentration of the exposed samples in Round 3 was estimated by 
the average nail tissue concentration of the four Exposed/Uncleaned samples (avg. 11.9 
µg/g Mn).  The Round 3 contamination level was quite close to the Round 2 average 
Exposed/Uncleaned samples (avg. 10.2 µg/g Mn).  This is an indication that the 
contamination protocol is fairly reproducible for a maintained set of parameters (wire 
alloy, wire speed, arc time, etc.).  The reproducibility of this experimental design may 
prove useful toward further research in this area. 
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3-1 EU 31.40 227171.7 4.81 33.67 33.67 336.71 336.71 10.72 
3-2 EU 42.69 309839.2 6.56 45.92 45.92 459.23 459.23 10.76 
3-3 EU 30.09 282259.1 5.98 41.84 41.84 418.36 418.36 13.90 
3-4 UU 25.84 9708.7 0.21 1.44 1.44 14.39 14.39 0.56 
3-5 UU 39.74 7396.1 0.16 1.10 1.10 10.96 10.96 0.28 
3-6 EU 46.85 388135.0 8.22 57.53 57.53 575.28 575.28 12.28 
3-7 EC 22.48 7006.3 0.15 1.04 1.04 10.38 10.38 0.46 
3-8 UC 32.11 2750.6 0.06 0.41 0.41 4.08 4.08 0.13 
3-9 UC 23.10 2463.9 0.05 0.37 0.37 3.65 3.65 0.16 
3-10 EC 35.18 12868.6 0.27 1.91 1.91 19.07 19.07 0.54 
3-11 EC 36.00 20881.3 0.44 3.09 3.09 30.95 30.95 0.86 
3-12 UC 42.44 3348.3 0.07 0.50 0.50 4.96 4.96 0.12 
3-13 UC 36.36 3533.4 0.07 0.52 0.52 5.24 5.24 0.14 
3-14 EC 44.89 26843.7 0.57 3.98 3.98 39.79 39.79 0.89 
3-15 W-EC 25.67 54612.1 1.16 8.09 8.09 80.94 80.94 3.15 
3-16 W-EU 46.90 209118.0 4.43 30.99 30.99 309.95 309.95 6.61 
3-17B W-EU 118.35 91552.2 1.94 13.57 13.57 135.70 1356.96 11.47 
3-18 W-EC 113.90 240012.2 5.08 35.57 35.57 355.74 355.74 3.12 
 
 
Table 4-8  Round 3 ICP-MS Spike Data 
ID Additional ppb Mn55 (cps) Delta cps 
2-5 0 7396.1 - 
3-5 + 0.71 ppb 0.7143 39192.0 31795.9 
3-5 + 1.43 ppb 1.4286 77135.1 69739.0 
3-5 + 2.86 ppb 2.8571 141510.1 134114.0 
3-5 + 5.71 ppb 5.7143 279262.0 271865.9 









CHAPTER 5. ANALYSIS 
Table 5-1 below shows the data for the W-EU and W-EC treatment groups pooled from 
all three rounds of testing.  Table 5-2 shows the data for the UU and EU treatment groups 
and Table 5-3 displays the data for the UC and EC treatment groups, likewise pooled 
from all three rounds of testing. The descriptive statistics and confidence limits for all 
data pooled from all three rounds are depicted in Table 5-4.  The following sections 
describe in detail the statistical analyses utilized to make judgment on the specific 
hypotheses associated with Objectives 1 through 3. 
 
 
Table 5-1  Groups W-EU and W-EC Pooled Data – All Rounds 
Sample Group Subject Nail Tissue 
1-9 W-EU WW13 FL 8.79 
1-12 W-EU WW15 FR 8.27 
3-16 W-EU WW10 FR 6.61 
3-17 W-EU WW17 FL 11.47 
1-10 W-EC WW13 FR 3.30 
1-11 W-EC WW15 FL 3.31 
3-15 W-EC WW10 FL 3.15 






Table 5-2  Groups UU and EU Pooled Data – All Rounds 
Sample Group Subject Nail Tissue 
1-1 UU JCB FL 0.19 
1-4 UU JCB FR 0.65 
2-1 UU JCB FL 0.44 
2-4 UU JCB FR 0.37 
3-4 UU JCB FR 0.56 
3-5 UU JCB FL 0.28 
2-2 EU JCB FR 8.43 
2-3 EU JCB FL 12.03 
3-1 EU JCB FL 10.72 
3-2 EU JCB FR 10.76 
3-3 EU JCB FL 13.90 
3-6 EU JCB FR 12.28 
 
 
Table 5-3  Groups UC and EC Pooled Data – All Rounds 
Sample Group Subject Nail Tissue 
1-5 UC JCB FL 0.22 
1-8 UC JCB FR 0.16 
2-5 UC JCB FL 0.11 
2-8 UC JCB FR 0.14 
2-9 UC JCB FL 0.14 
2-12 UC JCB FR 0.11 
3-8 UC JCB FR 0.13 
3-9 UC JCB FL 0.16 
3-12 UC JCB FR 0.12 
3-13 UC JCB FL 0.14 
2-6 EC JCB FR 0.80 
2-7 EC JCB FL 0.46 
2-10 EC JCB FR 0.52 
2-11 EC JCB FL 0.51 
3-7 EC JCB FL 0.46 
3-10 EC JCB FR 0.54 
3-11 EC JCB FL 0.86 
3-14 EC JCB FR 0.89 
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S SE T95 LCL95 UCL95 E 
W-EU 4 8.784 2.016 1.008 3.182 5.577 11.992 3.207 
W-EC 4 3.220 0.096 0.048 3.182 3.068 3.373 0.153 
UU 6 0.415 0.174 0.071 2.571 0.232 0.597 0.182 
EU 6 11.354 1.851 0.756 2.571 9.412 13.296 1.942 
UC 10 0.143 0.034 0.011 2.262 0.118 0.167 0.024 
EC 8 0.630 0.185 0.066 2.365 0.475 0.785 0.155 
 
5.1 Normality Testing 
Before testing the study’s main hypotheses it was necessary to test each data set for 
normality in order to determine the proper statistical methods to apply.  As mentioned 
earlier in section 3-5, the methods applied were P-P and Q-Q plots (Theoretical-
Graphical), box plot (Descriptive-Graphical), skewness and kurtosis (Descriptive-
Numerical), and three Hypothesis-driven numerical methods, the Shapiro-Wilk, Chi-
Square and Anderson-Darling normality tests. For very small sample size, however, 
descriptive methods, whether graphical or numeric, are not very reliable, thus the 
hypothesis-based methods will be weighed much more heavily for decision making in 
determination of normality. 
 
5.1.1 Normality testing – P-P and Q-Q plots 
P-P and Q-Q plots are theory-based graphical methods because they relate experimental 
variable distribution data with a theoretical cumulative distribution function (CDF).  In 
this case the CDF is a standard normal distribution function.  The P-P plot compares the 
empirical data to the normal percentiles expected from a normal CDF while the Q-Q plot 
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compares the data to the normal quartiles expected.  The deviation of the experimental 
data from the normal CDF line indicates nonconformity with the normal CDF.  Figures 5-
1 through 5-12 depict the various P-P and Q-Q plots computed for this normality analysis. 
As will be evident in later normality tests as well, for the most part the data do not 
deviate excessively from the normal CDF, however the cleaned treatment group 
counterparts each of the uncleaned groups does seems to deviate more than the uncleaned 
group data.  This may indicate that the cleaning factor is in some way de-normalizing the 
data.  
 
5.1.2 Normality testing – Box plots 
Box plots are fairly self-representative illustrations of the 1st, 2nd (median) and 3rd quartile 
and maximum / minimum range in relation to the mean of the data set.  A normally 
distributed data series should display rather symmetric 1st and 3rd quartiles and the mean 
and median should be centered toward the middle of the box. 
 
Box plots were prepared for the three treatment group comparisons respective to the three 
major hypotheses.  Box plots displaying the 1st and 3rd quartile about the mean with a 
horizontal bar representing the median and vertical capped bars displaying the range were 
prepared as a graphical representation of the treatment group distributions. Groups W-EU 
and WEC, related to Hypothesis 1, are displayed in Figure 5-13, groups UU and EU, 
related to Hypothesis 2, are displayed in Figure 5-14, and groups UC and EC, related to 








Figure 5-2  Q-Q plot for normality for treatment group W-EU 
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Figure 5-4  Q-Q plot for normality for treatment group W-EC 
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Figure 5-6  Q-Q plot for normality for treatment group UU 
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Figure 5-11  P-P plot for normality for treatment group EC 
 
 




Figure 5-13  Box plot of W-EU & W-EC distributions 
 
It was apparent that the very small sample sizes within these treatment groups inhibits the 
utility of these box plots to provide much information about the nature of the normality of 
their distributions.  The plots however, do have some value in graphically displaying the 
descriptive statistics of the data sets.   
 
5.1.3 Normality testing – Skewness and Kurtosis 
Skewness and Kurtosis are descriptive numerical measures which indicate the degree to 
which a dataset diverges from a normal distribution.  Skewness is a measure of the 
dataset distribution symmetry.  A negative skewness value indicates skewness to the left  
70 
 
Figure 5-14  Box plot of UU & EU distributions 
 
(more observations to the right) and positive skewness indicates the opposite.  Skewness 
is given by the equation: 
 
Kurtosis is a measure of the dataset distribution peakedness. A kurtosis value below 3 
indicates that the dataset distribution has a lower peak and thicker tails than a normal 
distribution, while a value above 3 shows it has higher peak and thinner tails than normal. 




Table 5-5 exhibits the skewness and kurtosis results for the various treatment groups.  As 
with the box plot method the skewness and kurtosis method is of very limited power with 













S Skewness Kurtosis 
W-EU 4 8.784 2.016 0.720 1.475 
W-EC 4 3.220 0.096 -0.069 -5.430 
UU 6 0.415 0.174 0.125 -1.085 
EU 6 11.354 1.851 -0.370 0.713 
UC 10 0.143 0.034 1.686 3.618 
EC 8 0.630 0.185 0.617 -1.980 
 
 
5.1.4 Normality testing – Chi-Square Test 
The Chi-Square Test for distributional adequacy uses standardized values which are 
calculated for each data point and placed in to k number of bins.  The test statistic Χ2 is 
given by: 
 
Where Oi is the observed frequency by bin and Ei is the expected frequency for the 
particular bin i.  Ei is given as: 
Ei = N (F(Yu) – F(Yl)) 
Where Yu is the upper limit, Yl is the lower limit, F is the particular distribution function 
being tested, and N is the sample size.  
 
The results of the Chi-Square test for normality are seen in Table 5-6 below.  For all 
groups except UC and EC, p-values for the Chi-Square Test were clearly high enough to 
accept the null hypothesis that the sample data could have come from a normal 
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distribution.  The EC group, however, came much closer to the rejection level at p = 
0.1092.  Group UC clearly had a Chi Square Test p-value low enough to reject the 
normality assumption (p = 0.0011).  As we will see in the other hypothesis-based 
numerical methods, it is the cleaned groups which seem to be trending away from the 
normality assumption. 
 
Table 5-6  Results of Chi-Square Test for normality 
Group n Mean Mn (µg/g)  S 
Chi 
Square df P value 
W-EU 4 8.784 2.016 0.616 3 0.8927 
W-EC 4 3.220 0.096 1.238 3 0.7440 
UU 6 0.415 0.174 0.007 3 0.9998 
EU 6 11.354 1.851 0.007 3 0.9998 
UC 10 0.143 0.034 16.080 3 0.0011 
EC 8 0.630 0.185 6.050 3 0.1092 
 
5.1.5 Normality testing – Shapiro-Wilk Test 
The Shapiro-Wilk Test derives a positive value (W) which is less than or equal to one. 
Closeness to one indicates normality.  The W measure is a ratio of the best estimator of 
variance to the corrected sum of squares estimator of variance.  The W statistic is derived 
by regression of ordered data upon the matching expected values based on normal order.  
If the dataset is normally distributed, this regression will approach linearity.  Validity 
exists for the W statistic from a sample size range of 3 to 50.25  There are approaches to 
increase the range but they are not relevant to this study as none of the treatment groups 
approached n=50.  The W statistic is derived by: 
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Where x(i) are the ordered sample values and the ai are constants generated from means, 
variances, and covariances of the order statistics drawn from a normal distribution for a 
sample size of n.  Tables are available to draw the ai values from.  Once the W statistic is 
calculated it is compared against a critical value of W for a particular confidence level, 
typically an alpha level of 5%.  If the W statistic is greater than the critical value, the null 
hypothesis, that samples are drawn from a normal distribution, is not rejected.   
 
The results of the Shapiro-Wilk Tests are depicted in Table 5-7.  The p-value are all 
greater than the critical value of 0.5 except for treatment group EC (p-value 0.0249).  For 
all groups we cannot reject the null hypothesis that the data are normally distributed, 
although again one additional group approached rejection (UC).   Group W-EC, though 
not necessarily approaching rejection, was significantly closer to Wcrit than the three non-
cleaned groups.  There does seem to be some indication that the cleaning process itself is 
tending to deviate the data distributions away from normality. 
 





S VAR W Wcrit p-value 
W-EU 4 8.784 2.016 4.063 0.9627 0.748 0.7958 
W-EC 4 3.220 0.096 0.009 0.8327 0.748 0.1749 
UU 6 0.415 0.174 0.030 0.9817 0.788 0.9598 
EU 6 11.354 1.851 3.425 0.9669 0.788 0.8712 
UC 10 0.143 0.034 0.001 0.8495 0.842 0.0573 
EC 8 0.630 0.185 0.034 0.7927 0.818 0.0249 
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5.1.6 Normality testing – Anderson-Darling Test 
The Anderson-Darling Test is actually a modified Kolmogorov-Smirnov Test which 
weights the tail ends of the distributions heavier.  The test statistic, A2,is given by: 
 
Where Φ is the normal cumulative distribution function and Yi are the ordered data. The 
test statistic is compared to a critical value dependent on the specific cumulative 
distribution function.  The results of the Anderson-Darling Test are shown in Table 5-8.  
Similarly to the Shapiro-Wilk Test results, the Anderson-Darling Test results show 
acceptance of the null hypothesis that the data come from a normal distribution for all 
groups except EC, although the UC group again approached rejection.  Again it is seen 
that all of the cleaned nail groups trend toward rejection significantly more than the 
uncleaned groups.  
 





S VAR A2 p-value 
W-EU 4 8.784 2.016 4.063 0.231 > 0.250 
W-EC 4 3.220 0.096 0.009 0.402 0.179 
UU 6 0.415 0.174 0.030 0.138 > 0.250 
EU 6 11.354 1.851 3.425 0.227 > 0.250 
UC 10 0.143 0.034 0.001 0.568 0.105 




5.1.7 Normality testing – Synopsis 
As is the case with any study involving such small sample sized treatment groups, it is 
difficult to draw absolute conclusion about the normality of the dataset cumulative 
distribution function.  Based on the previous three hypothesis-based normality tests as 
well as the graphical methods, the only group which can reliably be rejected normality is 
group EC (at p-value 0.025)  It appears from the data that some factor related to the 
cleaning method is responsible for the trend away from normality for the cleaned groups.  
This is likely to be the case due to the within-subject nature of the samples.  
 
Based on the assumption of normality for all but one treatment group, Two-Group t-Tests 
of the difference of means for independent groups for sample sizes less than 30 were used 
to test the main study hypotheses.  In addition, modified box plots which display the 1st 
and 3rd quartile about the mean were prepared as above except with the vertical capped 
whisker bars displaying the 95% confidence intervals of the datasets instead of the data 
ranges.  This was done as the author believes it is a better graphical representation of the 
differences between datasets for such small sample size groups.  In addition, due to the 
fact that the EC group was not normally distributed and the other cleaned groups tended 
away from normality, the non-parametric hypothesis test, the Wilcoxon signed-rank test 
will also be run in parallel for each hypothesis analysis.  
 
5.2 Statistical Testing of Hypothesis 1 
Figure 5-16 shows a modified box plot (with confidence limits shown as capped whiskers 
instead of the typical range values) for the comparison of treatment groups W-EC and W-
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EU.  The difference between the means is of such magnitude that even with only four 
data points each, the confidence limits do not overlap.  This is a strong indication that 
there is statistical confidence that the W-EU group has a higher population mean than the 
W-EC group.  In other words, the uncleaned welder fingernails do indeed have a 
significant amount of exogenous Mn contamination on them, as was postulated in 
Hypothesis 1.   
 
 
Figure 5-16  Box plot mean with confidence intervals W-EU vs. W-EC 
 
The difference of means between UU and UC was only 0.272 µg/g Mn compared to a 
difference of means between W-EU and W-EC of 5.564 µg/g Mn.  As the W-EU and W-
EC samples came from welders and the fact that the control groups UU vs. UC showed 
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only about 5% of the difference between cleaned and uncleaned nail in the welder groups, 
it is proposed that the exogenous Mn found on the welder nails is most likely a result of 
welding fume to which they are occupationally exposed.  This indicates that external 
exposure to welding fume of the nail tissue conveys potentially long-term carry over 
contamination effect which must be dealt cleaned off in order to have valid use of nail 
tissue as an acceptable biomarker of Mn exposure  
 
To support this conclusion of Hypothesis 1, a Two Group t-Test was performed to 
challenge the independence of the means of the two treatment groups.  The results of the 
t-Test are displayed in Table 5-9 along with the equality of variances results from a 
folded F test show in Table 5-10. .  The test for equality of variance between the two 
groups resulted in an F statistic of 442.26 and a p-value of 0.0004, thus the variances are 
determined to be significantly different and either the Satterthwaite or Cochran methods 
for unequal variances can be used to provide a more conservative p-value for the t-test.  
These non-pooled approaches take a weighted average of the two group variances and 
determine a standard error for the t-test while the general pooled method takes an 
arithmetic average of the standard deviations of each group and converts that into a 
standard error.  Both non-equal variance methods still have very low p-values for the t-
test (0.0116 and 0,0117) resulting in rejection of the null hypothesis that the population 
means are equal.  The population mean in ppm Mn for the welder group uncleaned nails 
(W-EU) is significantly larger than the population mean for the welder group cleaned 
nails (W-EC).  This provides confirmation that the study’s Hypothesis 1, that welders do 
have significant exogenous contamination of Mn on their sampled fingernail tissue. 
79 
Even though both groups passed the hypothesis –numerical analyses for normality, the 
W-EC group had p-values less than 0.25 ( p = 0.175 Shapiro-Wilk Test and p=0.179 ).  
Therefore, non-parametric tests were also run to determine whether the population means 
Table 5-9  Two-Sample t-test results W-EC vs. W-EU 
Method Variances DF t p-value 
Pooled Equal 6 -5.51 0.0015 
Satterthwaite Unequal 3.0136 -5.51 0.0116 
Cochran Unequal 3 -5.51 0.0117 
 
Table 5-10  Folded F results for W-EC vs. W-EU t-test 
Method DF Den DF F Value Pr > F 
 Folded F 3 3 442.26 0.0004 
 
were significantly different under the assumption that one or both treatment group 
distributions were not a normal cumulative distribution function.  The tests chosen were 
the Wilcoxon Ranked Sum Test and the Kruskal-Wallis Test.  As will become apparent 
below, the shape and scale of the welder treatment groups sample distributions, and 
likewise those of the further comparisons made for the other hypotheses, were not equal.  
A major assumption of the Kruskal-Wallis Test is that the two groups have 
indistinguishable scaled and shaped distributions, with the exception for any difference in 
medians, an assumption the Wilcoxon Test does not presume.  Therefore, for the 
purposes of hypothesis testing the Wilcoxon Test was relied upon as the non-parametric 
parallel to the parametric Two-Sided t-tests performed. 
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The results of the Wilcoxon and Kruskal-Wallis Tests are presented in Table 5-11 and 
graphical representations of the treatment groups sample distributions (for nail tissue Mn 
concentration) are shown in Figure 5-17.   The graphical depictions of the distributions 
shows clear dissimilarity between the group sample distributions, thus the rejection of the 
Kruskal-Wallis Test.  A box plot depicting the distribution of Wilcoxon Test Scores for 
both treatment groups is presented in Figure 5-18.  The Wilcoxon test p-value for the 2-
sided normal approximation was significant at 0.0304 while under the t-distribution 
approximation the p-value was 0.0671, just approaching significance.  In light of the 
normality tests and the parametric methods above, the conclusion was made that the 
population means of these two welder treatment groups were significantly different. 
 
Table 5-11  Results of Wilcoxon and Kruskal-Wallis Tests for W-EC and W-EU 
Wilcoxon Test 
Kruskal-Wallis Test 
  Normal Approximation t-dist Approximation 
Z p - 1 sided 
p - 2 
sided 
p - 1 
sided 
p - 2 
sided Chi-Square df p - Chi Sq. 




Figure 5-17  Distributions of Toenail Mn (µg/g) for groups W-EC and W-EU 
 
Figure 5-18  Distribution of Wilcoxon Scores groups W-EC and W-EU  
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5.3 Statistical Testing of Hypothesis 2 
Figure 5-19 shows another modified box plot (with confidence limit whiskers) for the 
comparison of treatment groups UU and EU.  There is statistically significant difference 
between the means of the UU and EU groups, as would be expected due to the 
experimental design of intentionally contaminating the nails in the EU group and not 
cleaning them.  Additionally the dramatic gap between the confidence limits shows 
impressive  support of Hypothesis 2, that the welding fume exposure protocol of the 
experimental method does work and exposed nails did experience significant exogenous 
contamination of Mn by the welding fume. 
 
To support this conclusion of Hypothesis 2, a Two Group t-Test was performed to 
challenge the independence of the means of the two treatment groups.  The results of the 
t-Test are displayed in Table 5-12 along with the equality of variances results from a 
folded F test show in Table 5-13. .  The test for equality of variance between the two 
groups resulted in an F statistic of 113.75 and a  p-value of 0.0004, thus the variances are 
determined to be significantly different and either the Satterthwaite or Cochran methods 
for unequal variances can be used to provide a more conservative p-value for the t-test.  
Again, both non-equal variance methods still have very low p-values for the t-test (both 
had p-value < 0.0001) resulting in rejection of the null hypothesis that the population 
means are equal.  The study’s Hypothesis 2 is confirmed that nail tissue exposed to 
welding fume in the welding fume containment vessel after a 180s GMAW arc time and 
contained for 2 hours during deposition, does have significant exogenous contamination 
of Mn compared to paired within-subject unexposed nail tissue. 
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Figure 5-19  Box plot mean with confidence intervals UU vs. EU 
 
Table 5-12  Two-Sample t-test results EU vs. UU 
Method Variances DF t p-value 
Pooled Equal 10 14.42 < 0.0001 
Satterthwaite Unequal 5.0879 14.42 < 0.0001 
Cochran Unequal 5 14.42 < 0.0001 
 
Table 5-13  Folded F results for EU vs. UU t-test 
Method DF Den DF F Value Pr > F 
 Folded F 5 5 113.75 < 0.0001 
 
Again, though both groups passed the hypothesis –numerical analyses for normality (both 
had p > 0.87 Shapiro-Wilk and p > 0.25 Anderson-Darling), non-parametric tests were 
also run to fortify the statistical conclusions of the study in the event that one or both 
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treatment group distributions compared in Hypothesis 2 were not from a normal 
cumulative distribution function.  The tests chosen were the Wilcoxon Ranked Sum Test 
and the Kruskal-Wallis Test.  Once more, the shape and scale of the two control subject 
group sample distributions (EU and UU) were not equal.  Like before, for the purposes of 
hypothesis testing the Wilcoxon Test was relied upon as the non-parametric parallel to 
the parametric Two-Sided t-tests performed. 
 
The results of the Wilcoxon and Kruskal-Wallis Tests are presented in Table 5-14 and 
graphical representations of the treatment groups sample distributions (for nail tissue Mn 
concentration) are shown in Figure 5-20.   The graphical depictions of the distributions 
shows clear dissimilarity between the group sample distributions, thus the rejection of the 
Kruskal-Wallis Test.  A box plot depicting the distribution of Wilcoxon Test Scores for 
both treatment groups is presented in Figure 5-21.  The Wilcoxon test p-value for the 2-
sided normal approximation and t-distribution approximation were both significant at 
0.0051 and 0.0172 respectively.  Both the parametric and non-parametric methods lead to 
the conclusion that the population means of treatment groups EU and UU were 
significantly different. 
 
Table 5-14  Results of Wilcoxon and Kruskal-Wallis Tests for EU vs. UU 
Wilcoxon Test 
Kruskal-Wallis Test 
  Normal Approximation t-dist Approximation 
Z p - 1 sided 
p - 2 
sided 
p - 1 
sided 
p - 2 
sided Chi-Square df p - Chi Sq. 
-




Figure 5-20  Distributions of Toenail Mn (µg/g) for groups EU and UU 
 
 
Figure 5-21  Distribution of Wilcoxon Scores groups EU and UU 
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5.4 Statistical Testing of Hypothesis 3 
Figure 5-22 shows a modified box plot (with confidence limit whiskers) for the 
comparison of treatment groups UC and EC.  This comparison is actually the one with 
the highest sample sizes (n=10 for UC and n=8 for EC).  The difference between the 
means is not as great as the previous comparisons due to the fact that both of these groups 
have undergone the cleaning process.  However, the higher sample size and relatively 
low variance of the datasets is such that the confidence limits of the two groups are 
significantly separated.  This indicates that the population means of the treatment groups 
are different and that not all of the intentional exogenous Mn contamination deposited on 
the EC nail tissue was actually cleaned off by the cleaning protocol. 
 
 
Figure 5-22  Box plot mean with confidence intervals UC vs. EC 
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To support this conclusion of the rejection of Hypothesis 3, a Two Group t-Test was 
performed to challenge the independence of the means of the two treatment groups.   
The results of the t-Test are displayed in Table 5-15 along with the equality of variances 
results from a folded F test show in Table 5-16. .  The test for equality of variance 
between the two groups resulted in an F statistic of 30.31 and a  p-value of < 0.0001, thus 
the variances are determined to be significantly different and either the Satterthwaite or 
Cochran methods for unequal variances can be used to provide a more conservative p-
value for the t-test.  As with the previous t-tests, both non-equal variance methods still 
have very low p-values for the t-test (0.0001 and 0.0002 respectively) resulting in 
rejection of the null hypothesis that the population means are equal.  The study’s 
Hypothesis 3, that the cleaning process is cleaning off all the exogenous Mn 
contamination is rejected due to the fact that the t-test implies that the population mean of 
the exposed cleaned control nails is significantly larger than that of the unexposed 
cleaned control nails. 
 
Table 5-15  Two-Sample t-test results EC vs. UC 
Method Variances DF t p-value 
Pooled Equal 16 8.2 < 0.0001 
Satterthwaite Unequal 7.3704 7.34 0.0001 
Cochran Unequal . 7.34 0.0002 
 
Table 5-16  Folded F results for EC vs. UC t-test 
Method DF Den DF F Value Pr > F 
 Folded F 7 9 30.31 < 0.0001 
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Both groups trended away from normality in the hypothesis–numerical analyses for 
normality.  Group UC (p  = 0.0573 Shapiro-Wilk and p = 0.105 Anderson-Darling) was 
approaching rejection of normality, while group EC  (p  = 0.0268 Shapiro-Wilk and p = 
0.025 Anderson-Darling) was significant for rejection of normality. For this reason the 
non-parametric tests are most important for the Hypothesis 3 analysis.   The tests chosen 
were the Wilcoxon Ranked Sum Test and the Kruskal-Wallis Test.  Once more, the shape 
and scale of the two control subject group sample distributions (EC and UC) were not 
equal.  Like before, for the purposes of hypothesis testing the Wilcoxon Test was relied 
upon as the non-parametric parallel to the parametric Two-Sided t-tests performed. 
 
The results of the Wilcoxon and Kruskal-Wallis Tests are presented in Table 5-17 and 
graphical representations of the treatment groups sample distributions (for nail tissue Mn 
concentration) are shown in Figure 5-23.   The graphical depictions of the distributions 
shows clear dissimilarity between the group sample distributions, thus the rejection of the 
Kruskal-Wallis Test.   
 
Table 5-17  Results of Wilcoxon and Kruskal-Wallis Tests for EC vs. UC 
Wilcoxon Test 
Kruskal-Wallis Test 
  Normal Approximation t-dist Approximation 
Z p - 1 sided 
p - 2 
sided 
p - 1 
sided 
p - 2 
sided Chi-Square df p - Chi Sq. 




A box plot depicting the distribution of Wilcoxon Test Scores for both treatment groups 
is presented in Figure 5-24.  The Wilcoxon test p-value for the 2-sided normal 
approximation and t-distribution approximation were both significant at 0.0004 and 
0.0027 respectively.  Both the parametric and non-parametric methods lead to the 








Figure 5-24  Distribution of Wilcoxon Scores groups EC and UC 
 
 
5.5 Cleaning Method Effectiveness 
To estimate the effectiveness of the cleaning method in removing the intentional welding 
fume contamination it was necessary to first determine the total welding fume 
contamination concentration.  For this analysis only tissue samples from the same 
collection date paired for the specific difference of group means were used.  First the 
difference between means for groups EU and UU were calculated.  In this fashion any 
environmental Mn contamination on the control nails would not be taken into account in 
the calculation of total welding fume contamination. Next to be calculated was the 
difference between the means of the EC and UC groups.    The small level of residual 
environmental contamination for the control subject nails is insignificant compared to the 
welding fume contamination, thus this difference estimates the residual concentration 
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level of welding fume Mn contamination.  Table 5-18 depicts the differences of means as 
well as the associated confidence intervals for these two calculated values. 
 
To determine the amount of the Mn contaminant concentration removed by the cleaning 
process the difference of the differences of means was calculated along with the upper 
and lower range derived from the difference of the means confidence limits.  The percent 
reduction of the total welding fume Mn contamination is also presented along with the 
percent remaining on the nail tissue. These results are shown in Table 5-19.  The final 
residual WF contamination after cleaning was determined to be 4.45% ± 1.23% for a 
cleaning efficiency of 95.55%. 
 
Table 5-18  Confidence Interval for the Difference Between Two Means for EU–UU 
(WF Contamination) and EC-UC (WF Residual) for Within Subject Paired Samples Only 
MEU - MUU 10.94 MEC - MUC 0.49 
SEEU-UU 1.147 SEEC-UC 0.067 
VAREU-UU 5.258 VAREC-UC 0.036 
n 4 n 8 
df 3 df 7 
T95 3.182 T95 2.365 
LCL 7.601 LCL 0.342 
UCL 14.898 UCL 0.658 
 
Table 5-19  Effectiveness of the Cleaning Method by WF Residual Percent of WF 
contamination 
MEC-UC / MEU-UU      (or % Residual) 4.45% 
Lower limit 3.22% 
Upper limit 5.67% 
Cleaning Efficiency 95.55% 
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CHAPTER 6. DISCUSSION 
6.1 Primary Findings 
 
Significant Mn contamination was observed on fingernails sampled from occupationally 
exposed welders indicating the necessity of proper cleaning methods to remove such 
contamination.  Development of a methodology to contaminate control subject fingernail 
tissue with GMAW welding fume was establish and using said method a primary nail 
tissue cleaning protocol was investigated for its efficacy.  Though statistically significant 
levels of residual welding fume Mn contamination were present on the nail tissue post-
cleaning, the protocol was able to eliminate 95.55% of the contamination Mn.  
 
6.1.1 Occupational Exogenous WF Contamination to Fingernail Tissue 
The results of this study indicate that welders have significant exogenous Mn from 
occupational exposure which needs to be cleaned off in order to have a valid nail 
biomarker of internalized exposure from WF Mn  This was shown through the evaluation 
of Hypothesis 1. 
 
Though the study design did not facilitate a true determination of the amount of residual 
occupational welding fume Mn external contamination after the cleaning process, it was  
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clear from the sheer amount of Mn removed from the welder fingernails that significant 
exogenous contamination has occurred.  Even if some of the welders occupational 
contamination did remain, the level of Mn reduction from cleaning the welder nails, 
[WEU – WEC] (difference of means 5.56 µg/g Mn, margin of error 2.47 µg/g Mn) was 
nearly twenty times the apparent level of Mn reduction from the cleaning of unexposed 
control nails, a likely level of environmental external Mn contamination, [UU – UC] 
(difference of means 0.27 µg/g Mn, margin of error 0.15 µg/g Mn). It will be of interest 
to see how they welder fingernails compare to welder toenails for this level of 
occupational external nail contamination.   
 
Whether toenails are more protected from the welding fume environment than fingernails, 
due to boots, shoes, socks, etc. needs to be determined.  There could even be differing 
mechanisms involved in levels of residual Mn after cleaning for finger and toe nail tissue.  
Perhaps the abrasive environment of toenail inside shoes and socks, grinds WF Mn into 
the outer nail keratin matrix, resulting in less external contamination than fingernails but 
which may be harder to remove.  Toenails have been selected by most researchers in this 
field because of the perceived protective nature of foot coverings, but the true differences 
and similarities between toe and finger nail tissue with regard to cleaning of exogenous 
WF Mn has not been determined to date. It is possible that fingernail tissue may have 
been overlooked too hastily.  Some possibilities toward future research which may shed 
light on this issue are discussed below. 
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6.1.2 Effectiveness of Design for GMAW Contamination of Nail Tissue 
The GMAW generation, containment, and deposition methods developed in the study 
were effective at contaminating nail tissue with WF Mn, as observed by the analysis of 
Hypothesis 2.   Exposed uncleaned samples (means 11.35 µg/g Mn, margin of error 1.94 
µg/g Mn) were significantly higher than the unexposed uncleaned samples (means 0.42 
µg/g Mn, margin of error 0.18 µg/g Mn) 
 
Repeatability of the design was also indicated.  The nail tissue Mn concentration of the 
exposed samples in Round 3 was estimated by the average nail tissue concentration of the 
four Exposed/Uncleaned samples (avg. 11.9 µg/g Mn).  The Round 3 contamination level 
was quite close to the Round 2 average Exposed/Uncleaned samples (avg. 10.2 µg/g Mn).  
This is an indication that the contamination protocol is fairly reproducible for a 
maintained set of parameters (wire alloy, wire speed, arc time, etc.).   
 
The conclusion is that the methodology and experimental design presented through this 
study, will allow researchers to predictably and repeatedly expose nail tissue to WF Mn 
during further research into the use of nail tissue as biomarker for WF metals exposure. 
 
6.1.3 Efficacy of Nail Tissue Cleaning Method for GMAW WF Mn 
The current cleaning protocol was shown unable to remove all the exogenous WF Mn 
contamination.  The EC and UC treatment groups indicate significantly different 
population means by both parametric and non-parametric test of conservative nature 
95 
(Two Sample t-test p = 0.0002 Cochran method; Wilcoxon Test p = 0.0027 2-sided t-
distribution approximation). 
 
Despite the fact that there is statistical significance that the cleaning method did not 
remove all of the welding fume contamination it is worth noting the magnitude of effect 
the cleaning method did have on the nail tissue Mn concentration of the exposed nails. 
 
Based on the large contamination deposition seen in the EU samples, however, it does 
appear that the cleaning protocol is removing a relatively large proportion of the external 
Mn contamination.  The difference seen between the means of the UU and EU treatment 
groups (10.94 µg/g Mn; Margin of Error 1.69 µg/g Mn) represents the amount of 
contamination deposited during the exposure and the difference between the means of the 
UC and EC treatment groups (0.49 µg/g Mn; Margin of Error 0.14 µg/g Mn) represents 
the residual contamination after the cleaning method.  This indicates that roughly only 
4.45% (Margin of error 1.23%) of the welding fume Mn contamination remains as 
residual contamination after the cleaning protocol. In other words 95.55% (Margin of 
error 1.23%) of the welding fume Mn contamination presented on exposed nail tissue in 
this study was cleaned by the current cleaning protocol, supporting the notion that the 
current cleaning protocol is likely to prove to be an acceptable cleaning method.  Further 
research will be needed to identify the cleaning efficiency of the protocol for removal of 




6.1.4 Residual WF Mn and  
The author’s speculation on the potential reasons for the residual uncleaned Mn 
contamination include possible covalent bonding of Mn to sulfhydryl bridges in the 
keratin proteins on the surface of the nail tissue as well as potential for Mn to become 
chelated to the Triton X-100 surfactant and a certain amount of that surfactant may stay 
bound to the nail tissue even after the DDI rinse step via hydrogen bonding or van der 
Waals forces.  Further investigation into the degree of and binding nature of residual WF 
Mn contamination is essential to understanding the use of nail tissue as a biomarker for 
WF exposure.  Potential future work is discussed below. 
 
It is also apparent from the UU vs. UC comparison (confidence limits do not overlap), 
that there is either a certain degree of environmental Mn contamination on the control 
subjects nails (0.49 µg/g Mn; Margin of Error 0.14 µg/g Mn), perhaps from exposure to 
Mn in tap water via bathing, hand washing, etc., or there is some degree of leaching 
effect by the cleaning process which may be removing some of the bio-metabolized 
internal nail Mn.  
 
The utility of nail as biomarker for WF Mn exposure will likely rely heavily on the 
relative efficiency of the cleaning process to leave low levels of contamination which are 
significantly less that Mn tissue concentrations expected to have neurodegenerative effect.  
The ability of the cleaning protocol to remove the significant majority of GMAW WF Mn 
contamination in this study (levels twice that found on occupationally exposed welder 
nails) suggests valid use of nail tissue as biomarker for WF Mn exposure.   
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Another issue at hand is the potential for Mn to bypass the regular lung metabolic route 
and travel directly to the brain via the olfactory nerve.  Elder found that after 12 days of 
exposure to Mn ultrafine particles (UFP) via inhalation route, exhibited a 3.5 fold 
increase in in Mn concentrations in the olfactory bulb while lung Mn levels merely 
doubled.27   Elder concluded that the olfactory neuronal pathway was effective for 
transport of inhaled Mn oxide (UFP) to central nervous system tissue which can result in 
inflammatory changes. Elder suggests that similar pathways exist in human olfactory 
systems as well.27  Henriksson and Tjalve also found olfactory transport of Mn directly to 
the brain, bypassing the blood brain barrier.  They concluded that the neuronal cell 
pathways along the olfactory nerve deliver Mn straight to the olfactory bulb.28 
 
It is the author’s belief that the fraction of occupational airborne welding fume exposure 
which travels the olfactory route is likely to have fairly low variance among welders and 
likewise the fraction of exposure through the lung pathway should also stay relatively 
consistent.  It is therefore likely, that even if some degree of WF Mn exposure is not seen 
in the nail tissue because of the olfactory route, the nail tissue should still highly correlate 
with both the olfactory route fraction and the lung route fraction.  Thus the nail tissue use 
as a biomarker for WF Mn exposure should still be valid regardless of the potential for 
separate routes of inhalation exposure to the brain and body.  Nail Mn concentration 
likely will still correlate to neurodegeneration tests and disease outcomes.  Future work 
will hopefully reveal the ratio of olfactory route versus lung route from welding fume 
exposure so that it can be incorporated into the methodology and analysis of nail tissue as 
biomarker. 
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6.2 Limitations of this study 
 
6.2.1 Single control subject 
One issue with this study was the use of the single control subject.  While it was helpful 
in some respects, for testing the overall methodology of the contamination method, the 
fact that only one control subject was used means that the variability of human 
endogenous and environmental Mn contamination was not discernable in relation to the 
contamination method and the cleaning protocol.  Larger studies in the future may 
address these issues. 
6.2.2 Limited sample sizes 
The sample sizes of the individual treatment groups were also quite small and it is 
difficult to establish a normal range for control or welder groups Mn levels.  Again, 
future studies will likely address this issue by incorporating larger sample sizes. 
 
6.2.3 Artificial Method of Exposure  
While actual fresh GMAW WF was specifically chosen as the contaminant for the study, 
as opposed to MnCl WF dust etc., it was a rapid contamination rather than an extended 
external exposure over the full term of the nail growth.   Also the nails did not experience 
any trauma or physical abrasion between exposure and testing as would be expected 
during the course of nail tissue growth.  Future study designs will not to address this issue 
to get a clearer picture of the relative efficiency of the cleaning process on actual 
occupational WF Mn exposure over the full growth term of the nail tissue. 
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6.2.4 Fingernails vs. Toenails. 
This study utilized fingernail tissue for logistical reasons.  In the majority of nail 
biomarker for WF exposure studies, toenail is the chosen nail tissue, due evidently to the 
presumed protective environment of shoes and socks6,11,15 and, as is the case with The 
Wabash Study, welders often cannot provide adequate tissue sample mass from 
fingernails but can with toenails.   
 
Welder finger nails were shown to have significant exogenous contamination in this 
study, but this work needs to be repeated with toenails to ensure the uncertainty and 
efficiency of the cleaning method is similar with toenail tissue.  The findings of this study 
that welder fingernails carry excessive exogenous contamination seems clear evidence for 
need of reliable cleaning method,  though an understanding of the exogenous 
contamination effect on welder toenails and whether footwear has a sheltering effect 
crucial to understanding the utility of this method.  For the Wabash Study cohort welders 
which were investigated in this study an average post cleaning fingernail Mn 
concentration was found to be 3.22 µg/g while the corresponding toenail concentrations 
previous determined for the same welders had an average of 11.74 µg/g Mn.  As 
previously mentioned, fingernail tissue has an approximate growth rate twice that of 
toenail, leading to the speculation that fingernail tissue concentration would be roughly 
half that of toenail concentration.  In this study welder fingernail Mn concentration 
actually had only 27% of the toenail concentration.  The nature of this apparent 
discrepancy is not obvious at this time.  
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6.2.5 Unable to determine leaching effect 
Another limitation of this study was that its design lacked an ability to test for the 
potential leaching of endogenous Mn from the nail tissue by the cleaning method.  As the 
cleaning method did not include any harsh chemicals such as nitric acid, it was presumed 
that little leaching was occurring and that the difference between the unexposed 
uncleaned control nail and the unexposed cleaned control nail (UU – UC) was do to 
environmental external exposure, possibly from tap water.  Future studies should attempt 
to discern whether leaching is occurring and to what extent. 
 
6.3 Lack of literature 
It is unclear why there is no apparent literature on the subject of nail cleaning for use with 
nail being used for biomarker of welding fume exposure.  Multiple research groups are 
already using similar cleaning protocols as the method in the present study.  Presumably 
because they believe there is at least potential for exogenous welding fume contamination 
of the nail tissue samples and thus their use of the cleaning methods.  Future work will 
need to address the issue of optimal cleaning methods so that a consensus can be made on 
a standard cleaning method which will allow better comparison of nail study data. 
 
Eastman did do a study similar to this one in some ways, with treated hair and 
environmentally exposed hair.  The method of analysis for the hair was laser ablation 
followed by ICP-MS.  Eastman used five cleaning method procedures:  
(1) No cleaning; - hair was processed for analyses without cleaning.  
(2) MQ water  - rinse; hair was rinsed five-times with ultrapure MQ water.  
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(3)Triton sonication (T); hair was sonicated in 0.5% Triton X-100 for 10 min, 
rinsed five-times with MQ water, rinsed once with 1 N trace metal grade (TMG) 
nitric acid, and rinsed five-times with MQ water.  
(4) Triton and nitric sonication (TN); hair was sonicated for 20 min in 0.5% 
Triton, rinsed five-times with MQ water, sonicated for 10 min in 1 N TMG nitric 
acid, rinsed once with 1 N TMG nitric acid, and then rinsed five-times with MQ 
water.  
(5) 3×TN; the Triton and nitric acid sonication (TN) cleaning described above 
was performed three-times in succession. 
 
Hair samples from the subset of five subjects were intentionally contaminated with Mn 
containing environmental dust or two concentrations of Mn contaminated water (70 µg/L 
Mn and 700 µg/L Mn).  Samples were cleaned with the various procedures and analyzed 
for comparison.   
 
The baseline Eastman used as a reflection of endogenous Mn of the hair was the 
untreated Triton + nitric sonication .  She found the data to indicate that the TN cleaning 
method was able to remove even excessive contamination with Mn and other metals 
without overcleaning.  As in our study with the control nail tissue, Eastman found 
significant environmental exogenous Mn contamination (Untreated no cleaning mean 
0.833 µg/g Mn compared to the baseline untreated Triton + nitric mean 0.170 µg/g Mn) 
which amounts to 0.663 µg/g, not far off from the environmental contamination on this 
study’s single control subject.  The 3 times TN cleaning did, however, reduce the hair Mn 
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concentration further in each group (down to 0.066 µg/g Mn in the case of the untreated 
hair), which leads to speculation that continued repetitions of the TN method may be 
actually leaching out bio metabolized endogenous Mn from the hair tissue.  
 
Although none of her cleaning methods was exactly the same as this study’s method, the 
Triton sonication with DDI rinse plus single nitric rinse was probably the closest. For the 
dust contaminate hair the with the Triton sonication with DDI rinse plus single nitric 
rinse showed 0.593 µg/g compared to the same hair with Milli-Q water rinse at 0.573 
µg/g for a nearly 90% cleaning, though it must be added that Eastman did not show 
results for the contaminated uncleaned group.  For the highest dose water contaminated 
samples the Triton sonication with DDI rinse plus single nitric rinse had a mean of 2.31 
µg/g Mn compared to the simple Milli-Q water rinse samples at 10.5 µg/g Mn for a mere 
78% cleaning efficiency.  To be certain the simple Milli-Q water rinse may have had 
some effect thus the cleaning efficiency could be artificially low by these numbers.  That 
said, the results appear in the same rough efficiency window as the current study’s. 
 
6.4 Potential future work 
Further attempts will be required to more fully understand the nature of the welding fume 
nail contamination and whether other cleaning protocol alternatives will be able to 
remove all of the exogenous contamination without leaching of endogenous, bio-
metabolized Mn incorporated in the nail tissues keratin matrix.  Below are listed some 
potential avenues of future investigation into this area. 
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6.4.1 Effects of sonication 
Additional comparison of the cleaning method protocol using two types of sonicators will 
likely be performed.   The Branson Sonifier from the original cleaning protocol (400W 
power output converted to 20 kHz ultrasonic mechanical vibration) will be compared to a 
Mettler Cavitator Ultrasonic Cleaner bath (85W power output converted to 67 kHz) in 
order to determine whether the Mettler Cavitator provides comparable cleaning to the 
Branson Sonifier.  While the Branson Sonifier only has the capability of running a single 
sample at one time, the Mettler Cavitator can run 24 samples or more at one time, thus 
allowing researchers a chance to eliminate a bottleneck in the nail sample preparation 
procedure and increase the efficiency of the overall process. 
 
6.4.2 Alternative Cleaning Procedures 
As was seen in the Eastman study with hair, additional cleaning procedure options should 
be examined with nail as the biomarker.  Some options include multiple repetitions of 
cleaning procedures in succession, addition of metal chelation agents such as EDTA, or 
variations of the ultrasonic bath power, frequency, and duration.   In addition adding 
nitric acid to the cleaning solution to etch the outer surface of the nail tissue thus assisting 
removal of external contamination could be analyzed as well but this could lead to 




6.4.3 Nature of binding of residual exogenous Mn 
Transmission electron microscope (TEM) studies could be used to determine the nature 
of the adherence of exogenous Mn from welding fume and the effects the cleaning 
process have on endogenous nail Mn.  Proper experimental design could determine to 
what degree the exogenous Mn is covalently bonded to sulfhydryl bridges in the keratin, 
hydrogen or van der Waals bonded, adhered by loose physical deposition, or perhaps be 
physical entrapment through processes of friction or grinding of welding fume particles 
into the surface of the nail tissue.  
 
Laser ablation techniques such as those used with hair could also be useful in analyzing 
various depth layers of the nail to determine actual levels of exogenous Mn before and 
after cleaning. 
 
6.4.4 Cleaning for other metals (Pb, As, Cr, Cu, Zn, etc.) 
As the nature of the metal elements of occupational and environmental concern, behave 
quite differently, other research will be needed to investigate the usefulness of cleaning 
protocols for metals such as Pb, As, Cr, Cu, Zn, etc.  It will need to be determined if 
researchers could also successfully utilize nail tissue as a biomarker for those metals 
without distortion from external nail contamination or leaching effects of cleaning 
processes. This study and its experimental design may prove useful in further endeavors 
into the nature and validity of nail tissue as biomarker for welding fume exposures.  
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6.4.5 Relation between personal nail growth variability, clipping depth, and 
chronological window of exposure depicted by nail sample 
Nail growth rate variability in human populations have been reported. 10 An 
understanding of the true relation between the section of toenail sampled and the time 
frame of that samples growth (an hence exposure window) needs to be understood before 
practical application of this biomarker can come to fruition.  One approach would be to 
have nail tissue donors carefully mark their nails periodically during a longitudinal study 
in order to arrive at individual growth rates.  It might then be possible to measure the 
depth of clipping and relate that to the growth rate and the persons total nail bed length, 
in order to obtain a better vision of the exposure time window represented by the clipping.  
 
6.4.6 Within-Subject Welder Design to Ascertain Exogenous WF Contamination Level 
Another approach to attempting to discern the actual level of exogenous contamination 
on occupationally exposed toenail could be to run a within-subject design utilizing a 
protection method for one foot’s nails and not for the other.  Special enamel coatings with 
no Mn or perhaps a Teflon sock could be useful.  Of course this method would incur 
potential compliance bias from the welders which would have to be addressed.   
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CHAPTER 7. CONCLUSION 
It is crucial that exposure biomarkers be able to reveal levels of internalized body burden 
due to external sources.  Nail tissue may be such a biomarker if cleaning methods are 
employed which adequately remove potential external contamination which the nail may 
be presented with during the subject’s exposure period.  In the case of Mn exposure from 
welding fumes, this study has shown that such exogenous contamination does exist.  A 
method of applying GMAW WF contamination was designed, implemented and 
confirmed.  The contamination method was utilized to contaminate control welder nails 
successfully at approximately twice the contamination level seen on welder fingernails 
and the presented cleaning method protocol was shown to remove this contamination at 
an efficiency of 95.55%.   The results of this study support the validity and utility of nail 
tissue as a biomarker for welding fume Mn internal exposure.  As the cleaning protocol 
applied in this study is likely to result in similar removal of additional metals of interest, 
it is likely that nail tissue may also prove useful for measuring body burden of other 
occupational and environmental metal exposures as well. 
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Appendix A Nail Digestion and ICP-MS Sample Protocol 
1. Sample Preparation Prior to Microwave Digestion (No blanks) 
 
a. Place toenail sample in to 15 mL Falcon tube and clearly label the sample 
ID number. 
b. Fill Falcon tube with 10 mL of 1% Triton X-100 solution and seal with 
cap. 
c. Place Falcon Tubes in Branson Sonifier ultrasonic cleaning bath (only run 
one falcon tube at a time). 
d. Make sure caps are sealed, do not allow water to dilute Triton solution in 
Falcon tubes. 
e. Run water into the Branson Sonifier bath at proper rate to maintain level 
slightly above the nail sample and below the meniscus of the Triton X-100 
solution in the Falcon Tube.  
f. Set the Branson Sonifier for 15 minute dwell and 50% power level.   
g. Continue to monitor water level to ensure it neither overflows nor run 
below the nail sample level.  Proper sonication will be visually observed 
by the nail samples suspended and vibrating in the cleaning solution by 
ultrasonic cavitation occurring. 
h. Continue this process repeating steps a. through g. for each nail sample to 
be cleaned. 
i. After ultrasonic cleaning, rinse each sample 5 times with DDI water or 
until surfactant suds are no longer seen in the tube.  Use a clean small 
beaker as an intermediary when pouring out of tube to make sure no nail 
sample is lost in the sink.  Rinse the beaker out with DDI after completing 
the rinse of each sample. 
j. Place sample in drying oven (Zheng Lab) for 24 hrs at 60˚ C.  The 
polypropylene Falcon Tubes and tube racks are safe at this temperature. 
k. Carefully weigh each dried sample and record sample’s mass.  Do this 
immediately after the oven drying to ensure no moisture condensates on or 
absorbs back into the nail tissue. 
l. If microwave digestion will be performed immediately, place each cleaned 
and weighed sample into a microwave digestion vessel, place in the 
carousel and note the position carefully (carousel position will be the only 
indicator of the sample ID until after digestion).  After all samples are 
prepared in vessels in the carousel, proceed with Step 2. 
m. If digestion will be performed at a later time, samples can be placed back 
into their individually labelled Falcon tubes temporarily. 
n. Note we will not do a blank at this step because the blank would simply 




2. Microwave Digestion of Samples 
 
a. Take the carousel to a lab hood for this step.  Turn on fume hood fan. 
b. Wear proper PPE (nitrile gloves double layer, lab coat, and safety glasses).  
Concentrated nitric acid fumes and is highly corrosive and will cause 
damages to skin, eyes, mucosal membranes and lungs.  Work carefully 
and patiently.  Locate the nearest eyewash station prior to working with 
the concentrated nitric acid. 
c. Take care in noting the specific position ID number of the carousel in 
which each sample’s vessel is placed.  There no other identification will 
exist during the digestion phase.  Strict order of placement must be 
controlled.   
d. Place cleaned, dried and weighed samples individually into microwave 
digestion vessels and place each vessel into its proper identified position 
in the carousel. Create a vessel placement pattern in the carousel which is 
as evenly dispersed as possible to ensure even microwave dispersal during 
digestion. 
e. Using a 1mL micropipette, into each microwave digestion vessel add 
precisely 2.00 mL of ultrapure HNO3 (the current reagent is JT Baker 
Ultrex II 6901-05 67-70% Nitric Acid for trace metals analysis), place the 
plug in vessel, lightly screw cap on until resistance is felt, and seal the vial 
tightly with the MARSXpress tensioning tool. You will hear a click when 
it is tensioned properly.  Do NOT over tighten. 
f. Place carousel with all sealed digestion vessels in microwave digester unit. 
g. Place exhaust ducting end into the fume hood and ensure the hood fan is 
on. 
h. Update the microwave digester oven log book to indicate the date, time, 
power, and your initials for the runs you make. 
i. Turn on the oven.  Select “Load Method”  “User Method”  “Test WJ 
– Xpress”.  Setting for this method should be: organic; 600W, 100% 
power; Ramp time 15 minutes; control temp 200 degrees Celsius; hold 
time 10 minutes. 
j. Make sure carousel is properly seated in the oven, close door and run the 
“Test WJ” program. Ramp up lasts 15 min, cool down is 15 min.  Let 
exhaust an additional 1.5 hour to ensure all the nitric fumes have 
exhausted into the hood.  
k. Continue to observe the digestion for the entire cooking ramp up time of 
15 minutes.  If vessels are not sealed properly, nitric acid may burst or 
leak potentially contaminating other samples.  If this happens, the oven 
must be manually stopped by pressing “P/T” and then pressing “0”.  Let 
the oven chamber vent to the hood at least a few minutes, then open and 
remove the carousel to the hood for cleanup and resealing vessels.  Also 
clean out the oven chamber.  Once cleanup is complete re-run the 
digestion from the beginning. 
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l. After samples have cooled (approx. 2 hrs.), open the digester and put 
carousel in hood to prepare stock solutions.   
m. Once the entire digestion is complete, clean the entire inside surface of the 
oven chamber with DDI water and lab wipes to avoid contaminating later 
sample digestions.  
 
3. Stock Solution Preparation 
 
a. Ensure hood fan is on and carefully open the first vessel.  Take care as 
vessel may be pressurized and nitric may fume out as the seal is cracked.  
Shield yourself with you gloved hand as the vial is opened.  Be extremely 
careful to not spill any of the digested material. 
b. Each digested sample should be clear and completely digested in the 
vessel before proceeding.  If sample is cloudy or visible material remains 
in the nitric solution, re-seal and run an additional digestion (for nail 
samples this will rarely happen). 
c. Carefully pipette the digested sample/nitric mixture into a clean 10 mL 
Pyrex volumetric flask.  Drops of the mixture may be in the cap and vessel 
grooves, on the plug and along the walls of the vessel.  Use the 
micropipette to obtain as much of the sample mixture as possible.  Note: 
Use of a 2-20 ultra-micropipette with a capillary type tip can be very 
useful in capturing the tiny droplets from the difficult areas of the vessel 
and plug, however, when using be very certain to not suck too much 
solution into the micropipette as going beyond the capacity of the pipette 
tip could damage the micropipette.  
d. Pipette DDI Water until flask is filled to the 10 mL line.  Be sure to read 
the meniscus properly.  Go slow at the end, DO NOT overfill.  Dilution to 
exactly 10 mL is crucial for proper analysis of nail tissue metal 
concentration. 
e. Cover top of flask with a piece of parafilm.  Press thumb to top of flask to 
seal Parafilm carefully then shake and mix thoroughly. 
f. Pour this diluted digestion mixture into a Falcon Tube and label with 
sample ID, “Stock Solution”, and any other identifiers needed.  This will 
be the stock solution from which we will prepare further dilutions for ICP-
MS analysis. 
g. Prepare a “Blank Stock Solution” by adding 2 mL of the same ultrapure 
trace metals analysis grade concentrated nitric acid used for the digestion 
and 8 mL of DDI water into a Falcon Tube.  Seal, mix, and label as 
“Blank Stock Solution”. 
 
4. ICP-MS Blank Preparation 
 
a. Pipette 1 mL of  “Blank Stock Solution” and 6 mL of DDI water into a 
Falcon tube. Label as “Blank”. 
b. Seal tube with lid and mix again. 
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c. Depending on the total number of sample to be run, multiple blanks may 
need to be prepared in this manner and provided to the MS lab.  If you are 
unsure how many to prepare, ask Karl. 
 
5. ICP-MS Sample Preparation 
 
a. Pipette 1 mL of stock solution and 6 mL of DDI water into a Falcon tube. 
Label with Sample ID. 
b. Seal tube with lid and mix again. 
c. Continue for each sample stock solution until all sample preparations are 
prepared. 
d. Note that procedure will have to be completed twice for each sample if 
performing samples from air filters because of a mass concentration range 
difference between Mn and Fe. 
 
6. Standard Dilution Preparation (for spiked ICP-MS samples) 
 
a. Place a cleaned and dried 250 mL narrow mouth HDPE bottle on the scale 
and tare. 
b. Pour precisely 199.8 grams of DDI water into the bottle. 
c. Use a calibrated micropipette to pipette 200 uL (microliters) of 10 ppm 
trace metals standard into the bottle.  Our current reagent is Exaxol - 68 
Element Standard - Part A - MS68A-100 which has 10 ppm of 49 
elements, including Mn, Cu, Fe, Pd, and Zi.   
d. Cap tightly and mix thoroughly.  This is now the 10 ppb standard to be 
used as a spike. 
e. Label as “Wabash Study 10 ppb Standard Solution”.  Date the standard 
solution preparation.  New 10 ppb standard solutions should be prepared at 
a minimum of every couple of months as 10 ppb level is less stable than 
the 10 ppm standard. 
 
7. Spike Addition Preparation (Must be done for each sample batch sent to the lab) 
 
a. Pick a moderate Mn level sample for use as spike samples.  This will 
either be a heavier sample weight control group nail sample or a lighter 
weight welder group nail sample.  Use this sample’s stock solution for 
preparation of the spikes additions.  Spiking an actual nail sample stock 
solution maintains common matrix effects from the constituents of the nail 
material. 
b. For “10 ppb addition” add 1 mL of the stock sample chosen above to a 
Falcon tube.  Add 1 mL “Wabash Study 10 ppb Standard Solution” and 5 
mL of DDI. This is technically a 1.429 ppb addition to the sample 
preparation after the further dilution is taken into account. 
114 
c. For “20 ppb addition” add 1 mL stock sample, 2 mL “10 ppb Standard 
Solution” and 4 mL of DDI.  This is technically a 2.857 ppb addition to 
the sample preparation after the further dilution is taken into account. 
d. For “30 ppb addition” add 1 mL stock sample, 3 mL “10 ppb Standard 
Solution” and 3 mL of DDI.  This is technically a 4.286 ppb addition to 
the sample preparation after the further dilution is taken into account. 
e. If higher levels are expected in the samples a “400 ppb addition” may be 
valuable as well.  It is good to have standard spikes which fall on either 
side of the majority of samples if possible. 
f. For “40 ppb addition” add 1 mL stock sample, 4 mL “10 ppb Standard 
Solution” and 2 mL of DDI.  This is technically a 5.715 ppb addition to 
the sample preparation after the further dilution is taken into account. 
 
8. Preparing Serial Dilutions of Stock Solutions (if necessary) 
 
a. If the expected range of sample preparation concentration for Mn is 
expected to be more than about 10-15 ppm or if the range is completely 
unknown, it is wise to provide the analytical chemists with serial dilutions 
of the sample preparations which may have high concentrations.  The 
chemists will be able to do a pre-run from most dilute to least dilute to 
determine which sample is best for the actual run to ensure optimal results.  
This also helps them to protect their equipment as high metal 
concentrations in samples can negatively affect their system.   
b. If serial dilutions are required, begin by preparing a 1/10th dilution (0.1X) 
of a sample’s stock solution by pipetting exactly 1 mL of the stock 
solution into a clean 10 mL Pyrex volumetric flask and pipette DDI water 
until flask is filled to the 10 mL line.  Be sure to read the meniscus 
properly.  Go slow at the end, DO NOT overfill. 
c. Cover top of flask with a piece of Parafilm.  Press thumb to top of flask to 
seal Parafilm carefully then shake and mix thoroughly. 
d. Pour this diluted stock solution into a Falcon Tube and label with sample 
ID, “0.1X Stock Solution”, and any other identifiers needed.  This will be 
the 1/10th serial dilution stock solution from which you will prepare a 0.1X 
serial dilution sample preparation.   
e. If further serial dilutions are necessary, continue in a stepwise manner 
using the 0.1X Stock Solution to create a 0.01X Stock Solution and so on. 
 
9. Preparing serial diluted ICP-MS sample preparations 
 
a. This is similar to the regular sample preparations with one addition.  The 
regular stock solutions have approximately 20% volume as 70% nitric acid 
resulting in 7mL sample preparations which have 2% nitric acid which is 
required for the ICP-MS analysis and to maintain proper matrix effect 
consistency of the sample preparation relative to the standard spikes and 
blanks.  Once a stock solution has been serial diluted its nitric acid 
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concentration becomes negligible and additional ultrapure nitric acid must 
be added to each serial dilution sample preparation in order to maintain the 
2% nitric acid required. 
b. Pipette 1 mL of serial diluted stock solution and 5.8 mL of DDI water into 
a Falcon tube labeled with Sample ID and the level of the serial dilution. 
c. Pipette 200 µL of ultrapure trace metals analysis 67-70% nitric acid into 
solution. Total volume should be 7 mL. 
d. Seal tube with lid and mix again. 
e. If serial diluted sample preparations are given to the MS lab, be sure to 
indicate precisely which they are and the nature of the serial dilutions to 
aid the lab. 
 
10. Preparing Entire Sample Run for ICP-MS Analysis 
 
a. Ensure that you have necessary blanks, spikes, and all sample preps for 
each type of metal analysis you need run. 
b. Place all Falcon tubes in Styrofoam holders.  Label holders 
“Rosenthal/Dydak”, the date, your initials, and the metals you want run. 
c. Label each sample only with ID number, on lid and tube.  Label spikes 
with chosen sample ID use to make the spikes and “+10ppb”, “+20ppb” 
and “+30ppb” respectively.  Label blanks “Blank” and clearly label any 
serial diluted samples. 
d. Send to Karl Wood in WTHR 157.  Analysis data return will take 




Appendix B Images of Welding Fume Contamination Process 
 
Figure B 1: Century 100 MIG Welder Used in Study 
 
Figure B 2: Safety Equipment For MIG Welding 
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Figure B 3: Placement of Nail Tissue for WF Exposure  
    
Figure B 4: Placement of the Spatter Shield 
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Figure B 5: MIG Arc Creating Welding Fume 
 
Figure B 6: Continuing Fume Generation 
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